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ABSTRACT

Isolation and Characterization of Paenibacillus larvae Bacteriophage for Use as a Potential
Treatment of American Foulbrood Disease in Honeybees

By

Diane G. Yost
Dr. Penny Amy, Examination Committee Chair
Professor of Biological Sciences
University of Nevada, Las Vegas

American foulbrood disease is a destructive honeybee illness cause by the bacterial
pathogen, Paenibacillus larvae. Current methods of treatment are either destructive or do not
completely eradicate the infection, and as such, undertaking further research to determine the
effectiveness of alternate treatment methods is of consequence.
The therapeutic use of bacteriophage that are capable of lysing host bacterial cells, or
phage therapy, is one such potential treatment. Phage are viruses that infect bacteria, and are
generally very host-specific. As such, targeting a pathogen would require obtaining phage
specific for P. larvae. Therefore, obtaining P. larvae phage requires screening environmental
samples likely to have phage capable of infecting P. larvae, enriching samples with P. larvae,
isolating any phage present, and characterizing the phage. After host range characterization, the
phage with the broadest host ranges of P. larvae strains but inability to target other species of
bacteria would be selected for use in a multi-phage cocktail. This cocktail would be used in
experimental treatments to determine the effectiveness of phage therapy in increasing survival of
honeybee larvae infected with P. larvae and eradication of AFB in an infected honeybee hive.
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CHAPTER 1

INTRODUCTION
Honeybees, Apis mellifera, are affected by a multitude of diseases including colony
collapse disorder, nosema, varroa mites, wax moth infestations, viral infections, and chalkbrood,
among others (Shimanuki and Knox, 2000). Such a variety of diseases is causing a decline in
honeybee populations (vanEngelsdorp and Meixner, 2010), a devastating reality for agriculture.
Honeybees pollinate approximately 35% of food crops worldwide (Klein et al., 2007) and
provide the agricultural industry in the United States an economic value of approximately $9
billion (Delaplane and Mayer, 2000). A decline in bee populations leads to a decline in
pollination, crop yield, and food supply (Potts et al., 2010). Hence, researching these diseases,
including potential treatments and preventative measures, is beneficial to the agricultural industry
and conservation strategies in general.
One honeybee infection, American Foulbrood disease (AFB), is caused by the bacterium,
Paenibacillus larvae (Shimanuki and Knox, 2000). This Gram-positive, rod-shaped bacterium is
capable of forming spores which are picked up by adult bees and brought back to the hive
(Genersch, 2010). Adult bees are resistant to the bacterial disease; however, they are vectors that
transmit the infectious agent to larvae that are susceptible (Hitchcock et al., 1979; Wilson, 1971).
Spores are resistant to antibiotics and heat; studies have shown that the spores of Paenibacillus
larvae in particular can persist for at least several decades (Genersch, 2010), which makes
eradication of this disease difficult. As few as 10 spores can cause the disease in a larva
(Woodrow, 1942; Woodrow and Holst, 1942). Once spores enter the gut of larvae, they
germinate and become vegetative bacterial cells (Bamrick, 1967) that proceed to grow and divide
in the larvae. In doing so, however, they compete with the larvae for nutrients, as well as
propagating to the point of rupturing the midgut lumen (Yue et al., 2008). The larvae disintegrate
1

into ropey masses, which deteriorate into scales; this condition is a characteristic trait of larvae
killed by this particular disease (Genersch, 2010). The death of one larva can produce millions of
spores which are then released in the hive (Sturtevant, 1932). As the larvae of a hive succumb to
the disease, and fewer bees are able to reach adulthood, the hive collapses as it is unable to
maintain its population. Currently, methods of treatment include the direct use of antibiotics in
hives as well as burning infected hives (Genersch, 2010). The former method has caused
increased antibiotic resistance in strains of P. larvae (Evans, 2003), as well as residual antibiotics
in honey that is sold for human consumption (Ortelli et al., 2004; Saridaki-Papakonstadinou et
al., 2006). Additionally, there is evidence of decreased hive immunity to protect the bees from
future recurrence of AFB following antibiotic treatment (Hawthorne and Dively, 2011). The
latter method of treating the disease is incredibly costly to the beekeeping community and results
in the decrease of hive materials, equipment, and productive hives, leading to significant
economic loss (Genersch, 2010). Therefore, the prevalence and seriousness of the AFB,
combined with the lack of effective and safe methods of treatment, has created the need for
research into alternate methods of treatment.
One potential method of treatment is bacteriophage, or simply phage, therapy. Phage
therapy is the therapeutic use of viruses, or phage. Phage are capable of infecting and lysing
bacteria (Carlton, 1999), with specificity for targeting certain bacterial species. Having a specific
host range means the bacteriophage can lyse the species of interest without killing even closely
related species, ensuring the survival of beneficial or harmless bacteria. A phage cocktail,
capable of infecting P. larvae but specific to this species, would potentially treat a beehive
infected with AFB without harming the native fauna or beneficial microbiota of the hive.
Previous work has explored the characteristics of single phage isolated from lysogenic strains of
P. larvae with the intent of developing a potential treatment strategy for AFB (Gochnauer, 1955;
Gochnauer, 1970; Drobnikova and Ludvik, 1982, Popova et al., 1976; Valerianov et al., 1976;
2

Dingman et al., 1984; Bakheit and Stahly, 1988; Campana et al., 1991); however, none of the
previous research led to a treatment regime for AFB. Bacteriophage are natural entities that
already exist in the environment, are not genetically modified, are self-propagating, would
decrease the need for chemicals, and would be harmless to bees or humans. Therefore,
researching the potential for use of phage therapy in treating AFB is of interest.
Because no recent isolates of phage to infect P. larvae are available, the first step in
developing a potential AFB phage therapy treatment is conducting an environmental search for
phage capable of lysing P. larvae. An extensive environmental search for P. larvae phage has
neither been done nor is available; therefore, conducting an environmental search should include
investigating both materials related and unrelated to beehives to discover where appropriate
phage are found in nature and how prevalent they are. Noting the prevalence and sources for any
phage found would be useful for phage ecology, and preserving such phage would be crucial in
testing the ability for phage therapy. Therefore, in this research, both environmental and
commercial materials will be screened for P. larvae phage, any positive samples will be
characterized, and then these isolates will be used for experimental treatments.
Characterization of the phage is important to determine if multiple isolates might be
several different phage or are actually the same phage isolated from different sources, meaning
that a single phage could be ubiquitous. Characterization could also help to determine if newly
isolated phage have previously been characterized by other researchers as well as to evaluate the
potential for treating AFB. A spot test can be used to access the lytic capabilities of each phage
on as many strains of P. larvae as possible. This would allow the host range of each individual
phage to be determined and allow the patterns of lytic capabilities between phage to be compared.
Transmission electron microscopy will be utilized to visualize individual phage for the purpose of
comparing the morphologies of each.
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After phage characterization, a preliminary experimental treatment needs to be
conducted. Honeybee larvae will be infected with the spores of P. larvae, as described by
Gochnauer and L’Arrivee (1969) and by Brodsgaard et al. (1998). Treatments will include: a
negative control without either spore infection or phage treatment, a positive control with spore
infection only, a positive control with phage treatment only, an experimental treatment with
phage cocktails administered after spore infection, and an experimental treatment with phage
cocktails administered prior to spore infection. The survival rates of larvae with phage therapy
will be compared to survival rates of the controls. Additionally, it will be useful to determine the
ability of phage cocktails to prevent infection of AFB by introducing phage prior to infection.
Because germination of spores occurs in the gut of the larvae, both spores and phage will be
added to their food for ingestion.
Ultimately, the goal of the project is to determine the possible effectiveness and
feasibility of utilizing newly isolated bacteriophage from natural sources as a means to treat
American Foulbrood Disease in honeybees.
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CHAPTER 2

METHODS FOR DEVELOPING TREATMENT STRATEGIES AGAINST THE HONEYBEE
PATHOGEN PAENIBACILLUS LARVAE, THE CAUSAL AGENT OF AMERICAN
FOULBROOD DISEASE

FORWARD
This chapter is a compilation of work conducted by multiple research labs. Ms. Jasmin
Khilnani is responsible for the work concerning low abundance compounds under the direction of
Dr. Helen Wing and Mr. Israel Alvarado is responsible for the work concerning endospore
formation and collection under the direction of Dr. Ernesto Abel-Santos. Dr. Helen Wing is
responsible for extensive writing and editing of this manuscript. I do not take credit for the
research presented nor the written text in the aforementioned sections other than my own. My
contribution to the research of this manuscript was conducted under the direction of Dr. Penny
Amy and is solely the research concerning bacteriophage acquisition, Figure 4, Table 2, and
Table 3.
This chapter is formatted for submission to BMC Microbiology.
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Abstract
Background
Paenibacillus larvae is a Gram-positive, spore-forming bacterium that is the causal agent of
American Foulbrood (AFB), a disease which affects honeybee larvae. AFB leads to significant
losses in honeybee populations, which drastically affects the agricultural economy each year.
Consequently, there is a pressing need to develop new treatment strategies against P. larvae and
the disease it causes.
Results
The methods described in this report were developed as a first step in the investigation of new
treatment strategies against P. larvae. Three methodological advances are described and
compared to current methods, where they exist. A protocol is described that consistently yields
higher numbers of P. larvae spores than previously described protocols, regardless of the strain
tested. Furthermore, microscopic examination of the spore preparations reveals that the newly
devised protocol yields purer spores than previously described protocols. Secondly, two enhanced
protocols that test the antimicrobial activity of low abundance compounds found naturally in
resistant adult honeybees are presented. The advantages of these protocols are discussed. Thirdly,
protocols to isolate, enrich and purify bacteriophage that specifically kill vegetative cells of P.
larvae are fully described.
Conclusions
We anticipate that this new collection of methods will assist others working to investigate the
biology of and develop treatment strategies against P. larvae.

Background
According to a recent survey of American bee keepers, one-third of the country’s honeybee
(Apis mellifera) colonies did not make it through the 2012-2013 winter season (Charles, 2013 and
7

Spleen et al., 2013). This decrease in honeybee populations is alarming considering the role that
honeybees play in the pollination of many major crops and the potential impact they have on the
global economy (Crailsheim and Riessberger-Galle, 2001; Morse, 2000; and Breeze et al., 2011).
American Foulbrood Disease (AFB) is a contributing factor to the decline in honeybee
populations (Evans and Schwarz, 2011). AFB is the most widespread and destructive of the bee
brood diseases and, despite its name, is found worldwide wherever honeybees are kept
(Matheson, 1993 and Calderone, 2001). The Gram-positive, spore-forming bacterium
Paenibacillus larvae was found to be the causal agent of American Foulbrood Disease (AFB) in
1907 (White, 1907). The spores of this bacterium infect honeybee larvae within 72 h of eclosion
(hatching from the egg). This typically occurs when brood food contaminated with infectious
spores is fed to larvae by the nurse bees, which, like all adult honeybees, are resistant to AFB
(Wilson, 1971).
Paenibacillus larvae was originally classified in the genus Bacillus but was reclassified as a
separate genus in 1993 (Ash et al., 1993). Formerly, two subspecies, P. larvae pulvifaciens and
P. larvae larvae (Heyndrickx et al., 1996) were described, but more recently the sub-species
classification has been removed (Genersch et al., 2006).
The infectious spores of P. larvae are known to remain viable for at least 35 years (Haseman,
1961). Currently, eradication of P. larvae from infected hives can only be achieved by burning
the entire hive and all associated equipment (Matheson, 1993 and Calderone, 2001). However,
this highly destructive solution increases the economic losses associated with the disease. In some
cases, antibiotics offer an effective prophylactic treatment (Calderone, 2001), but antibiotics are
not recommended for the treatment of hives that are actively infected. This is because antibiotics
can select for resistant strains of P. larvae (Murray et al., 2007) and do not completely clear the
pathogen from the hive. Instead, vegetative P. larvae cells sporulate and remain quiescent until
antibiotic levels drop, at which time a new infection will occur (Calderone, 2001). The hives may
8

appear healthy until there is a new stressor, such as onset of winter, at which time the disease
reoccurs (Karen Bean, personal communication). In addition, antibiotic use has the potential to
lead to traces of the antibiotic in the honey of treated hives. For these reasons, the registered use
of antibiotics in the treatment of AFB has been withdrawn in many countries (Chan et al., 2011).
Clearly, there is a pressing need to improve upon the current strategies used to decrease the
incidence of this disease.
The methods described in this report were developed as a first step in the investigation of new
treatment strategies against P. larvae. Three methodological advances are described; 1) an
improved protocol that yields a significantly higher number and purity of P. larvae spores, the
infectious form of P. larvae, 2) enhanced protocols that test the antimicrobial activity of low
abundance compounds found naturally in resistant adult honey bees, and 3) the isolation,
enrichment and purification of bacteriophage isolates that specifically kill vegetative cells of P.
larvae. We anticipate that this new set of methods will assist others working on P. larvae.

Results & Discussion
An improved protocol for the development and collection of P. larvae endospores
Three procedures for in vitro sporulation of P. larvae are commonly used (Dingman,
1983; Dingman and Stahly, 1983; and Genersch et al., 2005) and described in de Graaf et al.
(2013). Traditional infection studies do not require large numbers of spores because the infectious
dose of P. larvae spores is extremely low (<10 spores per larva [Woodrow, 1942 and Woodrow
and Holst, 1942]). However, our in vitro and in vivo P. larvae germination assays required
abundant and highly purified spore preparations (Akoachere et al., 2007; Alvarado et al., 2013;
Howerton et al., 2011; Powell, 1950; Ramirez and Abel-Santos, 2010; Alvarez et al., 2010). In
our experience, the published protocols (described in [de Graaf et al., 2013]) do not yield
sufficient numbers of P. larvae spores for such studies. Consequently, a new method was
9

developed that reproducibly yields higher numbers of spores from different strains with greater
purity. Here, we present a comparison of our newly devised protocol with the protocol (de Graaf
et al., 2013) that has traditionally yielded the highest number of spores (Dingman; personal
communication).
For this comparative study of in vitro sporulation, three P. larvae type strains (B-3554,
B-3650, and B-3685; see Table 1) were chosen because reports indicate sporulation rates vary
from strain to strain depending on the conditions used. Using the previously published method
(Dingman, 1983 and de Graaf et al., 2013), the three P. larvae strains were induced to sporulate
on MYPGP solid growth medium. Previous reports indicate that sporulation efficiency declines
when high numbers of colonies are present on a plate (Dingman and Stahly, 1983 and de Graaf et
al., 2013), therefore spores were isolated from MYPGP plates with either low (50-200 colonies
per plate) or high (colony 1000-5000 colonies) colony densities after 7 days of incubation at
37°C. The resulting spores were repeatedly washed and pelleted as previously described
(Dingman and Stahly, 1983 and de Graaf et al., 2013). In contrast, using the newly devised
protocol, P. larvae strains were induced to sporulate on Tryptic Soy Agar (TSA) that was
incubated for 7 days at 37°C in 5% CO2. Each TSA plate was inoculated with 200 µl of an
exponentially growing culture (approximately 1.2 x 108 colony forming units, CFUs). P. larvae
strains produced lawns on TSA medium. A HistoDenz™ density gradient was used to harvest
spores from vegetative cells and cell debris (Akoachere et al., 2007).
The yield of viable spores from each protocol was determined after the spore-containing
sample was heated (to kill any remaining vegetative cells), serially diluted and plated on MYPGP.
The resulting number of CFUs represents an estimate of the number of viable spores present in
each sample (Figure 1A). Regardless of the strain or whether the spores were isolated from either
high or low density plates, the newly developed sporulation protocol yielded significantly higher
numbers of spores per TSA plate than the established MYPGP plate method (for strain B-3554,
10

4.66 x 109 CFU per TSA plate versus 3.12 x 102-1.21 x 107 CFU per MYPGP plate; for strain B3650, 9.73 x 106 CFU per TSA plate versus 9.08 x 105-3.61 x 106 CFU per MYPGP plated; and
for strain B-3685, 6.06 x 108 CFU per TSA plate versus 6.64 x 105-4.27 x 106 CFU per MYPGP
plate). Limiting the number of colonies per MYPGP plate increased spore yield over those
harvested from MYPGP plates with high colony densities for P. larvae strains for B-3554 and B3650, but not for strain B-3685. These data demonstrate that regardless of the strain used, the
newly developed protocol routinely yielded higher numbers of viable spores.
The purity of spore stocks was next determined by microscopic analysis of spore smears
stained via the Schaeffer-Fulton method. Percent purity was defined as the ratio of spores to total
count of vegetative cells and spores in a sample (Figure 1B). Microscopic analysis of spore stocks
prepared for strains B-3554 and B-3685 on MYPGP plates consisted of less than 20% spores. In
addition the spores, prepared using the MYPGP protocol, were frequently contaminated with cell
debris, although the amount of debris was difficult to quantify by microscopy. For example, spore
stocks generated from strain B-3650 had 100% purity, even though cell debris could be observed
by microscopy (Figure 2A). These results indicate that multiple washes used in the previously
reported protocol (Dingman and Stahly, 1983 and de Graaf et al., 2013) are not sufficient to
remove vegetative cells and cell debris from the spore stocks. Furthermore, lysis of bacterial cells
in spores stocks by heating is not recommended because nutrient release from vegetative cells has
been shown to trigger spore germination (Shah et al., 2008). In contrast, spores isolated using a
HistoDenz™ density gradient to separate the spores from vegetative cells and cell debris, worked
exceptionally well and yielded virtually pure preparations of spores (Figure 2B). We therefore
recommend the use of a HistoDenz™ density gradient to purify spores because of the ease and
non-disruptive nature of the procedure.
These experiments demonstrate that our newly devised in vitro sporulation method is
more effective than established protocols (Dingman and Stahly, 1983 and de Graaf et al., 2013).
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While we obtained significantly more spores using our method with multiple P. larvae strains, the
use of a density gradient during spore preparation ensured that we also obtained a pure spore
stock. Furthermore, use of a commercially available medium, TSA, facilitated spore production
since other protocols describe the use of specialized media that often require extensive
preparation and may not support the growth of all P. larvae strains. In sum, the newly devised in
vitro sporulation experiments described above will facilitate research into identifying alternative
treatments for American Foulbrood Disease in honey bee larvae. They are already being used to
generate spores for spore germination assays (Alvarado et al., 2013), larval exposure assays, and
spore decontamination studies (work in progress).
Assays to measure antibacterial activity of low abundance compounds against P. larvae
Typically, the susceptibility/resistance of P. larvae to antimicrobial agents is measured
using either disk diffusion assays or by determining the minimal inhibitory concentration (MIC)
on a series of agar plates (agar dilution) or in broth (broth dilution) which contain different
concentrations of the antimicrobial agents (as described in de Graaf et al., 2013). The primary
drawback of each of these methods is that large amounts of the candidate compound are required
for testing. To test the antibacterial activity of low abundance compounds against P. larvae, two
new methods were developed.
The first protocol is a modified zone of inhibition assay. Two microliters of low abundance
compounds were applied to a small hole punched into the center of a 3x R2 agar (described in
Methods) inoculated with P. larvae. The plates were incubated at 37°C and observed zones of
inhibition were measured after 24 and 48 h. By adding the candidate antibacterial compound
directly to the agar, diffusion was unimpeded, which does not always happen when molecules are
applied to paper disks. To aid diffusion of the compound through the agar plates, the
concentration of agar was lowered from 2% (w/v), which is traditionally used in disk diffusion
assays on P. larvae (de Graaf et al., 2013), to 1.5% (w/v). Rather than using MYPGP agar for the
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zone of inhibition assays, 3x R2 agar medium was chosen because; 1) P. larvae grows well on
this medium, 2) it is commercially available, 3) it has similar composition to MYPGP, which has
been used previously for similar assays (de Graaf et al., 2013) and 4) unlike other commonly
used broths, such as Brain Heart Infusion (BHI) medium, it does not contain sodium chloride,
which has been shown to inhibit the function of honeybee antimicrobial peptides (AMPs)
(Caseels et al., 1990; Chi et al., 2003; and Suttle and Fhurman, 2010). The primary advantage of
these protocol adjustments over currently published methods is that small aliquots of test
compounds can be applied to the inoculated agar, allowing compounds that are in low supply or
otherwise prohibitively expensive to be tested.
The second protocol developed is a 96-well plate assay. Briefly, 5 µl aliquots of the
compound, at varying concentrations, were incubated with 95 µl of P. larvae culture grown to
logarithmic growth phase in 3x R2 broth (R2B). Samples were incubated for 24 h and optical
density measurements were taken over time. Use of 3x R2B in these assays was found to decrease
P. larvae cell aggregates that are typically seen when this bacterium is grown in BHI broth, thus
eliminating inconsistencies in optical density readings. These protocol adaptations generated an
assay that is as quantitative as the MIC assay but uses much less compound than currently
published methods (de Graaf et al., 2013). These advances will allow large numbers of MIC tests
to be run under identical conditions, making these methods more suitable for low abundance or
expensive compounds.
Using these approaches, two active AMPs found in adult honeybees, apidaecin and abaecin,
were tested against P. larvae strain B-3554 and Escherichia coli strain MC4100. Previous reports
have indicated that each of these compounds is active against E. coli strains in liquid assays. The
inclusion of E. coli in our assays, therefore, provided a useful positive control (Caseels et al.,
1990 and Chi et al., 2003).
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First, E. coli was tested using both the zone of inhibition and the 96-well plate assays.
Strikingly, in the zone of inhibition assay that uses semi-solid media, apidaecin was the only
AMP to exhibit antibacterial activity (a zone of clearance 8 mm in diameter was observed for
apidaecin versus none for abaecin; Figure 3, A & C). Conversely, in our 96-well plate assays
using liquid media, both apidaecin and abaecin show modest, although statistically significant,
inhibition of E. coli growth over a 24 h incubation period (Figure 3, E & G) These observations
suggest that the 96-well plate assay is more sensitive for the detection of antibacterial activity of
low abundance compounds than the zone of inhibition assay for our control organism, E. coli.
We next tested the antibacterial activity of apidaecin and abaecin against P. larvae, to
determine whether our newly devised assays would be sensitive enough to screen low abundance
compounds for antibacterial activity against P. larvae. For P. larvae, both apidaecin and abaecin
were seen to display antibacterial activity in the 96-well plate assay using liquid media at the 12
and 18 h time points (Figure 3, F & H), but neither AMP showed any observable antibacterial
activity in the zone of inhibition assays (Figure 3, B & D). These data, once again, indicate that
the 96-well plate assay using liquid media is more sensitive than the zone of inhibition assay for
the detection of antibacterial activity of low abundance compounds. While we recognized that the
zone of inhibition assays, described above, are simple to set up, require cheaper supplies and do
not require expensive technical equipment to collect the experimental data (plate reader/
incubator), it is clear from the data collected that the 96-well plate assays provide greater
sensitivity and generate quantitative data that can be used to determine the potential of low
abundance compounds to be used as antibacterial treatments to inhibit the growth of P. larvae
populations. These findings also demonstrate that the antibacterial activity of a compound may be
masked when tested on semi-solid media, even though the agar concentration had been decreased
to 1.5% from the 2% agar concentration typically recommended for disk diffusion assays. This
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observation is worthy of consideration and has not been discussed in other protocol descriptions
to date (de Graaf et al., 2013; Caseels et al., 1990; Chi et al., 2003).
Acquisition, enrichment and isolation of bacteriophage that specifically lyse vegetative P.
larvae
Bacteriophage are highly specific to their host bacteria and are extremely abundant in nature
(Suttle and Fuhrman, 1984). Lytic phage enter bacterial cells, replicate and kill their host cell by
degrading the bacterial cell wall (lysis). In contrast, lysogenic phage reside within bacterial cells
in a quiescent state, but may become activated to enter a lytic cycle under certain conditions.
Bacteriophage capable of lysing P. larvae strains undoubtedly exist in nature and are likely to be
found in environments (soil, water) in and around infected beehives and in compounds derived
from honeybee products. To determine whether P. larvae specific phage have the potential to be
used as novel treatment strategies for AFB, protocols that specifically allow the isolation,
amplification, screening and purification of bacteriophage specific for P. larvae were developed.
Acquisition: To induce lysogenic bacteriophage from P. larvae, procedures adapted from
those described by Dingman et al. (Dingman et al., 1984) were used. Although it is common to
induce lysogenic phage to enter the lytic cycle using environmental stressors such as ultraviolet
radiation or chemicals (Mayer et al., 1969), in our experience these stressors were not necessary
for inducing lysogenic P. larvae phage. Cultures of various P. larvae strains were simply grown
overnight in liquid medium and pelleted by centrifugation. The growth medium was then filtered
to remove any remaining cells and the resulting filtrate containing liberated bacteriophage was
used as the starting material for phage enrichment.
To acquire phage from environmental and commercial samples derived from honeybee
products, a protocol was adapted from a method designed to isolate bacteriophage from soil
(Hurst and Reymolds, 2002). This method described agitating a 50 g soil sample in 50 ml of 10%
beef extract solution for 30 minutes. Since our environmental and commercial samples ranged in
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mass from 1 g to 5 g, we chose to incubate our samples in 10 ml of phosphate buffered saline
(PBS) pH 7.1 overnight. PBS buffer was used to facilitate the liberation of phage bound to
particulates in the sample without extensive growth of microorganisms. After 18-24 h, bacterial
cells and debris were pelleted by centrifugation and the supernatant was collected. Although the
original protocol (Hurst and Reymolds, 2002) suggested using a series of stacked filters to
remove bacterial cells from the samples, we filtered supernatants through 0.45 µm sterile syringe
filters. If samples of filtrates were discovered to contain contaminating bacteria upon plating, the
remaining sample was re-filtered using 0.2 µm sterile syringe filters. Filtrates free from bacterial
contamination were used as the starting material for enrichment of bacteriophage capable of
lysing P. larvae.
Enrichment: To enrich for P. larvae-specific bacteriophage, a P. larvae host strain free of
phage was required. Strain B-2605 (Table 1) was found to be phage-free after testing it for
lysogenic phage in our studies, and it was also used as a host strain in previous phage research
(Dingman, 1983). To test for the presence of phage from environmental and commercial samples,
portions of each filtrate were added to exponentially growing P. larvae strain B-2605 and the
mixtures were incubated at 37°C overnight. The following day, the supernatants containing
putative lytic phage were collected and once again filtered.
Screening & Isolation: To isolate independent isolates of phage, material from single
plaques was obtained from mBHI (modified BHI; see Methods) agar plates overlain with a soft
agar containing P. larvae strain B-2605 mixed with the filtrates described above. After overnight
incubation, plaques were clearly visible on plates, which contained filtrates positive for
bacteriophage capable of lysing P. larvae (Figure 4). This technique is similar to that described
by Hurst & Reynolds (2002), but uses a double-pass procedure similar to that described by
Bakhiet and Stahly [38]. Each isolated plaque sample and 1 ml of overnight culture of P. larvae
B-2605 was used to inoculate a 20 ml mBHI broth. After overnight incubation at 37°C, the
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supernatant containing the amplified bacteriophage was harvested and filtered. This procedure
was then repeated to ensure that independent pure isolates of bacteriophage were obtained
(Bakhiet and Stahly, 1988).
Using these protocols, a combined total of 157 P. larvae strains, environmental samples,
and commercial samples were screened for bacteriophage capable of lysing the pathogen. Of the
157 samples, 32 (20%) were found to contain viral particles capable of lysing P. larvae. More
than half of these independent phage isolates came from samples taken in and around beehives
(53%). Nineteen percent of phage were isolated from P. larvae lysogenic strains and the
remaining isolates were obtained from either commercial products containing honey or royal jelly
or other environmental samples (Table 2).
The original titers of 13 of these 32 pure isolates ranged from 10 plaque forming units (pfu)
per ml to 1.55 x 104 pfu per ml. These 13 (described in Table 3) were selected for additional
amplification to aid further characterization of the pure lysates (summarized in Figure 3). Using
the amplification protocol, titers typically increased by ≥99%. The maximum increase was 1 x
108 fold and the minimum was 1 x 106 fold.

Conclusions
The three sets of methods described above were developed as an initial step to aid the
investigation of new treatment strategies against P. larvae and the honeybee disease, AFB.
The first set of methods increase the efficiency of in vitro sporulation and harvesting of P.
larvae spores compared to current protocols. These advances will aid those studying the disease
process itself, because the spore is the infectious unit, but will also facilitate those attempting to
block infection by targeting the endospores specifically, either by inhibiting or triggering their
germination. The latter approach is currently being investigated (Alvarado et al., 2013).
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The second set of methods focuses on adapting existing protocols that allow the MIC of
particular compounds to be tested on P. larvae, so that low abundance compounds or compounds
that are prohibitively expensive for pilot testing can have their MIC established. Since adult
honeybees are resistant to AFB, it is likely that compounds found in adult honeybees but absent
from larvae will prove to be effective antibacterial compounds against P. larvae. This line of
investigation is the subject of ongoing research in our laboratories.
The third set of methods center on the premise that phage therapy can be used to eradicate P.
larvae from contaminated hives and equipment. Using the newly described protocols, naturally
occurring bacteriophage that are specific for P. larvae can be isolated, enriched and purified from
a variety of environmental and commercial sources as well as P. larvae lysogens. Using these
approaches, 13 pure phage isolates at titers of over 105 pfu ml-1 have been collected and are being
fully characterized to determine their potential to be used as naturally occurring phage
therapeutics against P. larvae.
We share these methods because we believe that these methodological advances will
facilitate research that is targeted towards the development of novel treatment strategies for P.
larvae and the devastating AFB disease of honeybees.

Methods
Preparation of P. larvae spores
Two methods for producing a large number of spores were compared. Method 1: A P.
larvae culture was serially diluted using MYPGP broth to obtain low (50-200 and high (1,0005,00) CFU per MYPGP plate. Sporulation on solid growth medium was performed as described
previously (Dingman, 1983; Dingman and Stahly, 1983; and de Graaf et al., 2013). Briefly, after
7 days of incubation, spores were removed from MYPGP plates by gently scrapping and washing
the agar surface with sterile water three times. The spore suspension was concentrated via
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centrifugation, the supernatant was discarded, and the remaining pellet resuspended in ice cold
water. Alternate centrifugation and pellet suspension steps were performed to clean spores. Spore
stocks produced in this manner were stored in sterile water at 4°C. Method 2: P. larvae strains
were grown on Tryptic Soy Agar (TSA; supplied by BD) for 7 days in a 5% CO 2 incubator at
37°C (Akoachere et al., 2007 and Alvarado et al., 2013). The resulting bacterial lawns containing
spores were collected by ﬂooding with ice-cold deionized water. Spores were pelleted by
centrifugation and resuspended in fresh deionized water. After three washing steps, the spores
were separated from their vegetative and partially sporulated forms by centrifugation through a
20%-to-50% HistoDenz™ gradient. The spore pellet was washed ﬁve times with water and stored
at 4°C.
Viability Assessment of Spores: The concentration of viable spores in each spore stock
was measured by heat resistant counts on MYPGP agar plates (Dingman, 1983). We diluted every
spore stock to an OD580 of 0.2 as a way to normalize the starting concentration of spores. The
diluted spore stocks were heated at 68°C for 15 minutes, diluted in water, and plated onto
MYPGP agar. Plates with 30-300 colonies per plate were used to calculate the heat resistant spore
counts per MYPGP plate used (Dingman, 1983). Heat-resistant counts were performed in
triplicate with two different spore preparations. Statistically significant differences (P<0.05) for
all pairs of mean heat resistant spore counts per plate were determined using a Student’s onetailed t test assuming equal variances.
Purity Assessment of Spores: Samples (10µl) of each spore stock were smeared onto
glass slides, air dried, and observed after Schaeffer-Fulton staining (Schaeffer and Fulton, 1933).
At least 10 images of each spore stock were acquired randomly, and three random images were
analyzed using image processing software (ImageJ). Purity of spore preparations was expressed
as: (number of spores/number of spores and vegetative cells in images) X 100. Statistically
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significant differences (P<0.05) for all pairs of mean spore preparations or percent purity were
determined using a Student’s one-tailed t test assuming equal variances.
Assays to measure antibacterial activity of low abundance compounds against P. larvae
Growth of bacterial strains: To prepare P. larvae inocula for each of our growth
inhibition assays, cultures of strain B-3554 were prepared by scraping frozen glycerol stocks
(20% v/v glycerol) with a sterile wooden stick and placing it in 5 ml 3x R2B. Cultures were
routinely grown for 16 h at 37°C with orbital shaking (MaxQ 4000 Thermo Scientific) at 325
rpm. These cultures were then sub-cultured (1:20) and subsequently grown using the conditions
described above because this was found to minimize cell aggregation in liquid culture. E. coli
strain MC4100 controls were streaked onto a 3x R2 broth with 1.5% w/v agar (3x R2 agar) and
incubated at 37°C overnight. Subsequently, a single colony of each strain was used to inoculate 5
ml 3x R2B. The liquid cultures of E. coli were grown at 37°C overnight with orbital shaking at
325 rpm.
Zone of inhibition assay: 500 µl aliquots of the P. larvae overnight culture were
harvested and centrifuged at 16,100 x g for 2 min. The supernatant was discarded and the cells
were resuspended in 150 µl of fresh 3x R2B. Each 3x R2 agar plate was spread with a 150 µl
aliquot of the resuspended P. larvae cells to ensure the growth of a robust bacterial lawn. After
the inoculum had been fully absorbed by the agar, a hole was punched into the agar using a
sterile, pre-cut pipet tip, and 2 µl of either honeybee AMP at a concentration of 250 mg ml-1
(Apidaecin or Abaecin (purchased from AnaSpec and GenScript, respectively)), antibiotic or
distilled water was added to the hole. The plates were sealed with Parafilm® to retain moisture
and incubated at 37°C for up to 48 h. The diameters of the zones of inhibition were measured
after 24 and 48 h of treatment. E. coli samples were prepared similarly; except that 250 µl of an
overnight culture was used to form the bacterial lawns.
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96-well plate assay: Overnight cultures of P. larvae were diluted, approximately 10 fold,
in 3x R2B liquid medium to an optical density at 600 nm (OD 600) of approx. 0.2. The inner wells
of a clear, flat-bottomed, 96-well plate (Greiner Bio-One) were filled with 95 µl of inoculum
treated with 5 µl of either the AMP at varying concentrations, antibiotic or distilled water
controls. The outermost wells were filled with 100 µl water in order to minimize evaporation and
other edge effects. Each plate was incubated for 24 h at 37°C in a Tecan m200 plate reader, which
shook the plate in orbital mode at 335.8 rpm for 5 min every 15 min (amplitude of 1.5 mm). Five
absorbance scans at 600 nm were taken for each well every 15 minutes and the average was
reported. Each condition was tested in five wells and tests were repeated three times. Growth
curves were plotted and used to determine whether the AMP and/or the antibiotic controls
affected cell growth by comparing the antimicrobial-treated samples to the water-treated controls.
Protocols for the enrichment, isolation and amplification of P. larvae specific bacteriophage
Growth of Bacterial Strains: The following stock cultures of P. larvae were used: B2605, B-3554, ATCC-25747, ATCC-25748, ATCC-49843, ATCC-25368, B-3688, and ATCC25367 (Table 1). In addition, two natural cultures isolated from infected hives were used: 2188
and 2231. P. larvae strains were routinely grown in BHI broth modified with the addition of 1
mM CaCl2 and 1 mM MgCl2 (mBHI), to enhance viral attachment in our assays (Hurst and
Reynolds, 2002). Soft agar overlays of 3 ml mBHI with 0.95% (w/v) agar and 1% (w/v) yeast
extract were used for phage screenings and titer platings. Yeast extract was added to enhance the
clarity of plaques that formed on the surface of an overlay (Gochnauer, 1970). Agar mBHI plates
with 1.5% (w/v) agar were used for experimental platings. Either mBHI or R2A plates were used
to maintain stock cultures. Although the P. larvae strains took 3 days to grow on R2A at 37°C,
the duration of viability of the bacterium on this medium was longer than on mBHI plates. Broth
cultures of P. larvae were grown at 37°C and shaken at 100 rpm in an environmental shaker
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(Barnstead LabLine MaxQ 4000) for 24-48 h to obtain a maximum density (OD600 ≈ 0.7). Plates
(both mBHI and R2A) were incubated at 37°C in a NapCo E Series Model 303 Incubator.
Isolation of Lysogenic Phage: To isolate lysogenic bacteriophage capable of infecting P.
larvae, procedures similar to those described by Dingman et al. (Dingman et al., 1984) were
used. Cultures of P. larvae were grown in mBHI broth at 37°C and shaken at 100 rpm overnight.
These were pelleted by centrifugation at 3,220 x g for 10 minutes (Eppendorf Centrifuge 5810) to
remove bacterial cells. Supernatants from the cultures were filtered through 0.45 µm sterile
syringe filters with cellulose acetate membranes (VWR) to remove any remaining cells. The
filtrate served as the starting material for phage enrichment.
Isolation of Phage from Environmental and Honeybee Products: To isolate bacteriophage
from environmental (such as soil, beehive propolis, beehive wax, etc.) or commercial samples
(such as lip balm containing beeswax or lotion containing royal jelly), samples ranging in mass
from 1 g to 5 g were weighed and placed in 10 ml phosphate buffered saline (PBS) pH 7.1. The
mixtures were then shaken in 37°C and 100 rpm overnight. The mixtures were spun at 3,220 x g
for 15 minutes and the supernatant was collected. Occasionally, hive materials were found to float
on the top of the supernatant. Under these circumstances, a needle and syringe were used to
puncture the wax or propolis to extract the supernatant underneath. Supernatants were filtered
through 0.45 µm sterile syringe filters to remove any remaining cells. If, upon plating, filtrates
were discovered to contain contaminating bacteria, they were re-filtered using 0.2 µm sterile
syringe filters. Cell-free filtrates were enriched for phage capable of lysing P. larvae.
Enrichment of Isolated Phage Samples: Bacteriophage enrichment was achieved using
standard techniques, as described by Hurst and Reynolds (2002). Briefly, aliquots of cell-free
lysates were added to 1 ml of a freshly grown, overnight culture of P. larvae B-2605. Samples
were then shaken in an environmental shaker at 100 rpm in 37°C overnight. The resulting
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supernatants containing propagated phage were centrifuged at 3,220 x g for 15 minutes and
filtered with a 0.45 µm sterile syringe filter.
Screening of Bacteriophage: To screen for bacteriophage, supernatants of the enriched
samples were plated onto mBHI plates using a soft agar overlay technique (Hurst and Reynolds,
2002). Phage lysates, lysate dilutions (mBHI), and mBHI agar plates were all warmed to 37°C
prior to plating to prevent premature solidification of the agar. Soft agar tubes were melted in a
beaker of boiling water, and molten agar was cooled to 60°C prior to use. A volume of 1 ml from
an overnight culture of P. larvae B-2605 and 1 ml of an enriched filtrate were combined in the
molten soft agar overlay, poured onto the surface of an mBHI plate, and it was evenly distributed
over the surface. After the overlays solidified, the plates were inverted and incubated overnight at
37°C (representative plate shown in Figure 4). Individual plaques were necessary to ensure a pure
phage type had been isolated.
Purification of phage isolates: Individual isolated plaques were scooped from the soft
agar overlay with a sterile wooden stick. The plaque and 1 ml of a freshly grown P. larvae culture
were used to inoculate 20 ml sterile mBHI broth. The bacterial cells from this overnight
enrichment were pelleted by centrifugation at 3,220 x g for 10 minutes, and the supernatant was
filtered using 0.45 µm sterile syringe filters. Whenever complete clearing of an overlay was
observed, higher dilutions of the filtrate were added to additional soft agar overlays in order to
visualize individual plaques. To ensure complete isolation and purification of each phage, a single
plaque was picked after a second round of plating and amplified again using the procedure
described above. This double pass procedure allowed pure independent isolates of bacteriophage
to be amplified in the lysate.
Further Amplification of Purified Phage Isolates: Individual broth cultures of 20 ml of
mBHI were inoculated with B-2605, B-3554, and ATCC-25748, incubated overnight at 37°C and
shaken at 100 rpm. On each day of the following 10 day process, 1 ml of each overnight culture
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was transferred to a fresh 20 ml of broth followed by incubation under the same conditions
described above. Each day, the cells in the remaining overnight broth culture were pelleted by
centrifugation at 3,220 x g for 15 min, the supernatant removed and the cell pellets resuspended
together in 15 ml of fresh mBHI broth. This cell mixture was distributed in 1.0 ml aliquots into
phage lysates on day 1 as well as each subsequent day for the 10 day period. The amplifying
phage lysate was, by this process, supplied with fresh cells of three bacterial strains daily to
further the amplification process. At the end of the 10 day amplification period, phage/bacterial
mixtures were centrifuged under the same conditions and the supernatant containing phage was
collected and filtered through 0.45 um sterile filters to remove cells and cell debris. Phage titers
were determined using the soft agar overlay method, as described previously.
Quantification of phage titers: To calculate the phage titer in a lysate, dilutions of the
starting lysate were plated in duplicate using the soft agar overlay technique (Hurst and Reynolds,
2002). The two plates from a dilution with numbers ranging from 30-300 were selected to ensure
statistical accuracy when counting. Plaques from the chosen dilution were then counted, counts
were averaged, and titers were calculated based on the dilution (Miller, 1998).
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Figure 1 - Effect of sporulation protocol on P. larvae strains spore production (A) Average number of heat
resistant spores for P. larvae strains spore stocks produced by two methods. The error bars represent standard
deviations from the mean obtained from at least three independent measures of CFU ml-1. (B) P. larvae spore stock
smears were analyzed via microscopy after Schaeffer-Fulton staining [39]. The error bars represent standard deviation
obtained from the mean based on at least three independent measures of purity. In all cases, the number of spores
collected using the new protocol was significantly higher (P < 0.05) than those collected using the old protocol.
Furthermore, the purity of the resulting spore samples was significantly higher when the new protocol was used (P <
0.05) compared to the old protocol, with one notable exception; spores harvested from strain B-3650 using the new
protocol were quantified to be equivalently pure as spores harvested using the old protocol.
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Figure 2 - Purity of spore stocks determined by microscopic analysis (A) Representative image of spore stocks
stained using the Schaeffer-Fulton method [39] prepared for strain B-3650 (A) on MYPGP or (B) the new protocol.
Cell debris retained safranin-O dye while spores retained malachite green dye. The scale bars indicates 10 micrometers.
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Figure 3 - Comparison of assays used to measure the antibacterial activity of honeybee AMPs. Representative
images from zone of inhibition assays (A-D) or data from 96-well plate assays (E-H). Results obtained with the
honeybee AMP apidaecin (top four panels). Results obtained with the honeybee AMP abaecin (bottom four panels).
Bacterial strains used were E. coli, strain MC4100 (A, E, C & G) and P. larvae, strain B-3554 (B, F, D & H). Images of
zone of inhibition assays (A-D) were taken after 22 h of growth. For the 96-well plate assays (E-H), all samples had an
OD600 of 0.2 at time 0 (data not shown). Error bars represent standard deviations from the mean for five replicate
samples and statistical significance between each AMP-treated sample and the water-treated (0) sample was determined
using a Student’s t-test assuming equal variance. Stars (*) indicate p-values of p ≤ 0.05.
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Figure 4 - Representative plate of a soft agar overlay with a bacteriophage capable of lysing P. larvae. The image
shows a lawn of bacteria containing plaques. This demonstrates that bacteriophage capable of lysing P. larvae were
present in the filtrate added to the soft agar overlay.
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TABLE 1: Strains of P. larvae used.
Previous
Species
subspecies
classification
P. larvae
larvae

Source &Strain
numbera

Isolationa

Distinguishing
featuresb

Isolated from insect, EC
Holst
Isolated from insect, H
Shimanuki
Isolated from insect, H
Shimanuki
Isolated from diseased
honeybee, RE Gordon
Isolated from diseased
honeybee larvae, NRRL
Isolated from larvae
scales, courtesy of Jay D
Evans (USDA)
Isolated from larvae
scales, courtesy of Jay D
Evans (USDA)
Powdery scale of
honeybee larvae, RE
Gordon
GW Skyring

Non-sporeformer

P. larvae

larvae

NRRL B-2605/
ATCC-9545
ATCC-25748

P. larvae

larvae

ATCC-25747

P. larvae

larvae

NRRL B-3650

P. larvae

larvae

NRRL B-3554

P. larvae

larvae

Designated 2188

P. larvae

larvae

Designated 2231

P. larvae

pulvifaciens

NRRL B3685/ATCC-49843

P. larvae

pulvifaciens

N.D.
N.D.
Spore-former
Spore-former
Spore-former

Spore-former

Spore-former, virulent

ATCC-25368/
N.D.
24027
P. larvae
pulvifaciens
ATCC-25367/
GW Skyring
N.D.
24026
P. larvae
pulvifaciens
NRRL BIsolated from diseased
N.D.
3688/ATCC 13537
honeybee, RE Gordon
a
Info obtained from American Tissue Culture Collection (www.atcc.org), Agriculture Research Services (ARS) Culture
Collection Database Server (nrrl.ncaur.usda.gov; formerly known as the Northern Regional Research Laboratories,
NRRL) and straininfo.net. bEvaluated in house. N.D., none determined

TABLE 2: General characterization of final phage isolates
Total Number of Isolates in Each
Category of Sources
Category
Soil around beehives
9
Beehive materials
8
Lysogenic phage from P. larvae
6
strains
Other
9
Totals:
32
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Percentage Found in Each
Category
28.13
25
18.75
28.12
100

TABLE 3: Bacteriophage titers
Purified Phage Lysate
Titer Before
(Isolate #)
Amplification (ml-1)

Titer After 5-day Amplification
Procedure (ml-1)

1

495

1.66 x 108

2

57

6.00 x 106

3

20

4.30 x 107

4

38

1.04 x 107

5

1750

1.84 x 108

6

400

3.40 x 105

7

150

3.66 x 107

8

15,000

3.97 x 106

9

10

1.59 x 107

10

15,500

1.17 x 107

11

500

9.40 x 106

12

795

7.45 x 107

13

22

1.29 x 107
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This chapter is formatted for submission to Applied and Environmental Microbiology.
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Abstract
American Foulbrood Disease (AFB) is caused by an infection of honeybees with the bacterium,
Paenibacillus larvae. To date, there are no nondestructive, effective treatments for this disease;
hives and associated equipment are burned as an extreme measure to prevent contamination. This
practice threatens agricultural productivity by both destroying the honeybees that are essential for
pollination of crops and, to a lesser degree, by destroying costly equipment. One potential
solution to control the pathogen and its spread is the use of bacteriophage that infect P. larvae.
To find and describe environmental bacteriophage, 157 samples were obtained from many
diverse sources including: P. larvae strains harboring prophage; various soils; wax, honey, royal
jelly and propolis; cosmetics containing products derived from beehives; plants and flowers;
compost; water and air samples. Bacteriophage were screened on BHI plates using soft agar
overlays containing additional salts and yeast extract (mBHI). High titer lysates were prepared in
mBHI broth containing P. larvae and a bacteriophage. Of the 157 samples, 30 were positive for
at least one bacteriophage capable of growing on P. larvae strain 2605 for a total of 32; two
sources produced two phage isolates each. The following indicate the percentage of phagepositive samples within each category: lysogens, 54.5%, cosmetics, 22.7%, soil under hives,
18.8%, beehive materials, 15.9%, and other environmental sources, 14.8%. After isolation,
bacterial host ranges were analyzed for further characterization.

Introduction
One of many diseases affecting honeybees, Apis mellifera, is American Foulbrood
disease (AFB) which is caused by the bacterium, Paenibacillus larvae (Shimanuki and Knox,
2000). This Gram-positive, rod-shaped bacterium produces spores, which are inadvertently
picked up by adult bees and transported back to hives (Genersch, 2010). While adults are
resistant to the disease, they are vectors that transmit the infective agent to larvae, which are
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susceptible (Hitchcock et al., 1979 and Wilson, 1971). Spores, in general, are resistant to
antibiotics and heat, and studies have shown that the spores of P. larvae in particular can persist
for at least several decades (Genersch, 2010), making eradication of this disease difficult.
Furthermore, following infection and death of one larva, millions of spores can be produced and
released in the hive (Sturtevant, 1932). Susceptibility of honeybee larvae to P. larvae infection is
during the first 36 h after hatching (Genersch, 2010). As the larvae of a hive succumb to the
disease, and fewer bees are able to reach adulthood, the hive collapses as it is unable to maintain
its population. Currently, the only viable method of treatment is the application of powdered
antibiotics directly applied and the current extreme measure to control the spread of the disease is
burning infected hives (Genersch, 2010). The antibiotic treatment method has caused increased
resistance in strains of P. larvae (Evans, 2003), as well as produced residual antibiotics in honey
that is sold for human consumption (Ortelli et al., 2004 and Saridaki-Papakonstadinou et al.,
2006). The method of burning infected hives to treat the disease is costly to the beekeeping
community, resulting in loss of hive materials, productive hives, and producing significant
economic loss (Genersch, 2010). Therefore, the prevalence and seriousness of AFB, combined
with the lack of effective and safe methods of treatment, has created a need for alternative
methods of treatment.
One potential method of treatment is phage therapy. Phage therapy is the therapeutic use
of viruses, or bacteriophage (also called phage) to kill bacterial cells. Phage are capable of
infecting and lysing bacteria (Carlton, 1999), with specificity for targeting certain bacterial
species. Previous studies have explored the characteristics of single phage isolated from
lysogenic strains of P. larvae. Several have suggested using phage as a potential treatment
strategy for AFB (Bakheit and Stahly, 1988; Campana et al., 1991; Dingman et al., 1984;
Drobnikova and Ludvik, 1982; Gochnauer, 1955; Gochnauer, 1970; and Valerianov et al., 1976);
however, no significant treatment strategies using phage have been reported.
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Bacteriophage are abundant in many natural environments (Suttle and Furhman, 2010).
Further, they are self-propagating only when host bacteria are present as well as being very
specific for targeted bacterial species. Phage, if used against P. larvae, would decrease the need
for chemical treatment of the hives and would not be harmful to bees, humans, or other microbes.
Therefore, researching the potential use of phage therapy in treating AFB is of interest in
economics and environmental health. Unfortunately, no ready repository of P. larvae phage is
available for use; therefore, various environments were screened for the presence of P. larvaespecific bacteriophage for use as a treatment strategy for AFB.

Materials and Methods
Growth of bacterial strains
The following strains of Paenibacillus larvae were used: NRRL B-2605, NRRL B-3554,
NRRL B-3650, ATCC-25748, ATCC-25747, ATCC-49843, ATCC-25367, ATCC-25368,
ATCC-3688. In addition, two naturally occurring cultures isolated from infected hives were
used: 2188 and 2231. Bacteria were grown for phage propagation under the same conditions as
described by Alvarado et al. (2014, submitted for publication) in a modification of Brain Heart
Infusion broth (BHI).
Environmental sampling technique
Environmental samples were obtained using alcohol flame-sterilized metal spoons and
placed into sterile Whirlpac bags. Samples were also collected remotely by individuals in other
locations using the same sampling methods. After collection, samples were stored at 4 °C until
shipment to UNLV.
Sample sources
Lysogenic phage were obtained by screening all 11 strains of P. larvae. Procedures
adapted from Dingman et al. (1984) were used. No special methods were needed to induce
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prophage as suggested by Mayer et al. (Mayer et al., 1969) from P. larvae strains because
sufficient numbers of phage became lytic during the growth of their host bacteria. Cells were
grown as described by Alvarado et al. (2014, submitted for publication). The presence of phage
was determined by plaque formation on a bacterial lawn of P. larvae 2605 using a soft agar
overlay method (Hurst and Reynolds, 2002).
Environmental phage were obtained from screening various soil samples, air samples,
cosmetics containing materials derived from beehives, and materials directly from beehives such
as royal jelly, wax, propolis, and honey. These samples were obtained from the following
geographic locations: Nevada, Washington, New Mexico, Oregon, Pennsylvania, New York, and
Iowa. Cosmetic sample sources, obtained from traditional retail settings, included various brands
of lip balms with or without honeybee derived additions. A combined total of 157 samples were
screened. Methods for preparing environmental samples are fully described in Alvarado et al.
(2014, submitted for publication). Filtrates free from bacterial contamination were used as the
starting material for enrichment of lytic bacteriophage capable of lysing P. larvae.
Phage enrichment, screening and isolation
Bacteriophage enrichment was achieved using standard techniques as described by Hurst
and Reynolds (Hurst and Reynolds, 2002). To enrich for P. larvae-specific bacteriophage, the P.
larvae host strain 2605 was used. This strain was utilized because it was phage-free after testing
for lysogeny using the technique described above, and it was previously used as a host strain in
phage research (Woodrow, 1942). Details of phage enrichment, screening and isolation are fully
described in Alvarado et al. (2014, submitted for publication).
Amplification of phage and determination of phage titers
Phage titers were determined by following the soft agar overlay technique described above.
Standard methods using two plates from a dilution with resulting plaque numbers ranging from
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30-300 were selected to ensure statistical accuracy. Plaques from the chosen dilution were then
counted, counts were averaged, and titers were calculated based on the dilution (Miller, 1998).
Soft agar overlay spot test
After amplification, each lysate was tested to determine its ability to form plaques on each P.
larvae strain and other bacterial species including: Paenibacillus polymyxa, Paenibacillus alvei,
Paenibacillus lentimorbus, Paenibacillus popillae, Escherichia coli, Shigella flexneri, Bacillus
cereus, Bacillus subtilis, Bacillus anthracis, Bacillus circulans, and Chromohalobacter sp. A 1
ml aliquot of sterile broth and 1 ml of an overnight culture of a single bacterial strain were added
to a tube of melted GmBHI agar (0.95%) containing 37 g BHI (Difco), 4g dextrose (Sigma), 1
mM of each CaCl2 and MgCl2 in 1L ddH2O. This mixture was then poured over a GmBHI agar
(1.5%) plate to create a bacterial lawn. Plates were divided into quadrants with 10 μl of a single
lysate spotted onto the surface of each quadrant creating quadruplicate testing. The ability to lyse
a P. larvae bacterial strain was measured by clearing. Each phage isolate was tested against each
bacterial strain using a scale from no evidence of lysis to complete clearing (Figure 1). All host
range results were recorded by the same individual for consistency. The phage with the broadest
host range and highest intensity of lysis were of interest as a potential treatment for hives infected
with AFB. Therefore, these phage were selected for further characterization. An exception was
made for a pair of phage with the same host range pattern but which were isolated from very
different sources. Determination of the similarity within these pairs was of interest because they
might give some indication of geographic distribution.
EM grid preparation
To prepare a highly concentrated phage lysate, 20 identical soft agar overlay plates were
prepared by mixing P. larvae strain 2605 with sufficient phage to result in complete lysis of
bacterial cells. Plates were prepared with GmBHI (0.4% Difco glucose was added to mBHI)
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containing 1.5% agarose and overlays were made of GmBHI with 0.95% agarose. These plates
were incubated overnight at 37 °C.
Agarose removal and filtration: Five ml of PBS pH 7.1 was added to the surface of each
plate and was allowed to sit for 20 minutes. The top layer of the agarose overlay was then
scraped off using a sterile pipette tip, making sure the underlying medium was not disturbed. The
scraped agarose plus PBS was collected and transferred to a funnel lined with four layers of
cheesecloth to remove the agarose particles. The resulting liquid was then filtered through a
sterile 0.2 µm filter (Sartorus) using vacuum filtration to remove bacterial cells.
Concentration of phage: The filtrate was distributed into 50 ml polysulfone centrifuge tubes
(VWR) and phage were pelleted by centrifugation for 15 hours at 4 °C and 18,000 x g (Beckman
J2-HS). The supernatant was removed and the centrifuge tubes were briefly inverted, being
careful to prevent the phage pellet from completely drying. The phage pellet was gently
resuspended in 1.0 ml of phage buffer, pH 7.5 with a composition of 10 mM Tris-HCl, 10 mM
MgSO4, and 68 mM NaCl (Dr. Malcom Zellars, personal communication), using a cut-off 1 ml
sterile, disposable pipette tip, then removed from the centrifuge tube and transferred to a 1.5 ml
microcentrifuge tube. The starting volume of approximately 100 ml was concentrated to a final
volume of 3 ml. This concentrated phage preparation was used to prepare grids for TEM
imaging.
Grid preparation: Using a carbon-coated copper grid (Ted Pella), 10 µl of each concentrated
preparation was placed onto the carbon surface and allowed to sit for 10 min prior to wicking
away the liquid with Whatman 541 paper wedges. The grid was rinsed (2X) for 2 min with
sterile filtered ddH2O, and the liquid was wicked away. The grid was stained for 2 min with 10
µl 2% uranyl acetate (pH 4.4), and the stain was wicked away before allowing the grid to air dry.
Grids were sent to the CAMCOR facilities at the University of Oregon for imaging.
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Results
Composition of phage and proportion of positive samples from each category
A total of 157 samples were screened, 32 of which were positive for viral particles. Table
1 displays the proportion of positive samples and Table 2 displays isolate sources.

Table 1. Proportion of samples found to contain P. larvae phage from each category.
Screened Samples
(#)

Samples Positive for Phage
Isolates (#)

Samples Containing
Phage (%)

Lysogenic Phage

11

6

54.5

Cosmetics

22

5

22.7

Soil Underneath Beehives

53

10

18.8

Hive Samples

44

7

15.9

Other Environmental Samples

27

4

14.8

Category
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Table 2. Sources, descriptions, and current designations of the 32 phage isolates.

Category

Cosmetics

Hive Samples

Soil Underneath
Beehives

Other
Environmental
Samples

Source

Phage Designation

Hand cream (contains beeswax and honey)



Body wash (contains royal jelly)

β

Lipbalm #1

IV

Lipbalm #2

V

Lipbalm #3

VIII

Scale from infected hive

XIII

Hive sample from Iowa

HU

Hive sample from Iowa (honey and wax)

YH/W

Propolis from beehive - Gilcrease Orchards, Nevada

H1P

Propolis from beehive - Gilcrease Orchards, Nevada

H2P

Propolis from beehive - Gilcrease Orchards, Nevada

H3P

Propolis from beehive - Gilcrease Orchards, Nevada

H5P

Soil underneath beehive - Gilcrease Orchards, Nevada

H1S

Soil underneath beehive - Gilcrease Orchards, Nevada

H2S

Soil underneath beehive - Gilcrease Orchards, Nevada

H3S

Soil underneath beehive - Gilcrease Orchards, Nevada

H4S

Soil underneath beehive - Gilcrease Orchards, Nevada

H5S

Soil underneath beehive - Pennsylvania

PAIIS1 fl

Soil underneath beehive - Pennsylvania

PAIS2 fl

Soil underneath beehive - Pennsylvania

PAIS2 med. cl.

Soil underneath beehive - UNLV, Nevada

III

Soil underneath beehive - Washington

WA

Garden soil - Summerlin, Las Vegas, Nevada

I

Garden soil - Summerlin, Las Vegas, Nevada

II

Air sample (gravity plates) - Las Vegas, Nevada

VI

Air sample (gravity plates) - Las Vegas, Nevada

VII

Phage from ATCC-49843

A

Phage from ATCC-25368

B

Phage from ATCC-25367

C

Phage from ATCC-25747

D

Phage from ATCC-49843

E

Phage from wild strain 2231

F

Lysogenic Phage
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Plaque morphology
Individual phage filtrates produced plaques in soft agar overlays, which were observed
and described based on size and morphology (Table 3). Plaques were classified based on sizes
and clarity. Plaque morphologies of the phage were as follows: 4 large, clear; 4 medium, clear;
3 small-medium, clear; 1 small, clear; 1 pinpoint, clear; 1 small, turbid; and 5 pinpoint, turbid.
Although there was a distribution of sizes, in general, there were more large, clear plaques than
small, clear plaques and more small, turbid plaques than large, turbid plaques.

Table 3. Morphology of plaques of each phage observed in soft agar overlays. Asterisk* formed plaques with a turbid
halo around a clear plaque center. Sizes ranged and were described using set plaque diameters in the following
classifications: pinpoint (<0.1 mm), small (0.1 mm – 0.5 mm), medium (0.5 mm – 1.0 mm), and large (>1.0 mm).

Phage
Designation

Plaque Morphology
Size

Clarity

Large
Pinpoint
Medium
Pinpoint
Large

Clear
Turbid
Clear
Clear
Clear

V*

Large

Clear

H2S
H3S
E
H5S
VII

Small-medium
Medium
Pinpoint
Medium
Pinpoint

Clear
Clear
Turbid
Clear
Turbid

D
PA1S2 - fl.
B

Large
Pinpoint
Pinpoint

Clear
Turbid
Turbid

VIII
PAIS2 - med. cl.
Sigma

Small
Medium
Small

Turbid
Clear
Clear

Small-medium
Small-medium

Clear
Clear

XIII
H1P
WA
HIS
F

IV
VI

Host range distribution
The host range of each of the 32 isolated phage on each of 27 different bacterial strains
was conducted by spot test experiments (as described in the methods) to determine how specific
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each of the isolated phage are to the genus Paenibacillus and more specifically the species P.
larvae. The data is presented in Figure 1.
None of the isolated bacteriophage caused lysis on the following strains: Paenibacillus
polymyxa, P. alvei, P. lentimorbus, P. popilliae, Escherichia coli C600, E. coli W3104, E. coli
MC4100, Shigella flexneri AWY3, S. flexneri BS103, Bacillus subtilis, B. anthracis, B. circulans,
and Chromohalobacter sp, indicating host specificity to the genus Paenibacillus as well as the
species P. larvae.
Three phage, H1P, WA, and H1S, lysed all P. larvae strains tested, and F lysed all strains
with the exception of its host strain, 2231. In addition, these phage with broad host ranges on P.
larvae were also highly lytic on multiple strains (+++). One exception was XIII, which was
highly lytic on only four P. larvae strains. The isolated lysogenic phage were generally not
capable of lysing the host strain from which they were isolated, with the exception of D and A,
and these only produced a +/- result.
There is no apparent correlation between the source and the effectiveness of the phage
against P. larvae strains.
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Figure 1. Host range of 32 isolated P. larvae bacteriophage determined by soft agar overlay spot tests. Results are
interpreted on a scale from no lysis (blank cell) to complete lysis (black cell). Phage are designated by letters and
numbers, corresponding to the source from which they were isolated. The bacterial species are represented across the
top and are ranked from left to right in order of susceptibility to lysis by the 32 phage. The isolated phage are listed on
the left side of the table and are ranked from top to bottom in order of the percentage of P. larvae strains they are
capable of lysing.

Isolated
Phage

NRRL B-2605
2188 Isolate
NRRL B-3554
ATCC 25748
ATCC 25747
NRRL B-3650
2231 Isolate
ATCC 25367
ATCC 49843
ATCC 3688
ATCC 25368

P. larvae

H1P
WA
H1S
F
V
H2S
H3S
E
H5S
VII
D
PAIS2 fl.
B
VIII
PAIS2
σ
A
III
HU
IV
VI
I
β
H4S
C
XIII
H2P
H3P
YH/W
II
PAIIS1
H5P

Figure 1 Key. Range of spot test descriptions
observed in the host range experiment. The host range
results are interpreted on a scale from no clearing to
complete clearing. Plated examples show
representative images of phage lysis on a bacterial
lawn.
Description

44

Color
Code

Result
Scale

No clearing

-

Faint outline
where lysate
was placed

+/-

Visible
clearing

+

Entire area has
been lysed but
still turbidity
within plaque

++

Entire area is
completely
lysed; no
turbidity

+++

Plated
Examples

Susceptibility of phage lysis on former P. larvae subspecies larvae and P. larvae subspecies
pulvifaciens
There is a distinct difference between the susceptibility to the 32 isolated phage of strains
formerly designated as P. larvae larvae and P. larvae pulvifaciens. Sample variances of P. larvae
pulvifaciens and P. larvae larvae were 0.0237 and 0.0046, respectively. Using Welch’s t-test,
t=4.169, degrees of freedom ~5.727, and p=0.0087. Assuming ≤ 0.01, there is a significant
difference between the susceptibility that each group of former P. larvae subspecies has to the P.
larvae bacteriophage. The two strains that were isolated from an infected hive were not classified
under the same former subspecies as the repository strains, and were therefore not included in this
calculation.

Figure 2. Proportion of susceptibility to isolated phage of P. larvae strains, which are grouped by former subspecies.
Bacterial strains are listed from back to front.

Proportion of Bacteriophage Isolates that
Lyse Each P. larvae Strain

Susceptibility to Paenibacillus larvae Bacteriophage
of Former Subspecies of P. larvae
P. larvae pulvifaciens

1

P. larvae larvae

0.8
0.6
0.4
0.2
0
NRRL B-2605
ATCC 25367

NRRL B-3554
ATCC 49843

ATCC 25748
ATCC 3688

ATCC 25747
ATCC 25368

Bacterial Strains
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NRRL B-3650

Comparison of phage morphology using TEM.
Results for 16 phage that were confidently imaged are given based on morphological
descriptions only, the following are the possible families of these isolated phage: 13
Siphoviridae, 1 Podoviridae, 1 potential Inoviridae, and 1 potential Tectoviridae (Table 4). Even
among phage potentially classified under the same family, there are size variations of heads and
tails. Sample images are presented in Figure 3.

Table 4. Morphologies of chosen phage determined from TEM images. Images were provided by the CAMCOR
facilities at the University of Oregon. Measurements are based on the averages of 2-4 images. Question mark indicates
uncertainty of classification based on rarity of the family. Family classifications are based on descriptions of
morphology only.
Phage
Designation

EM Imaging Comparison
Head Shape

~Head Length
(nm)

~Head
Width (nm)

~Tail
Length (nm)

Possible
Family

H1P

Elongated icosahedron

109

55

227

Siphoviridae

A

Elongated icosahedron

114

71

212

Siphoviridae

WA

Elongated icosahedron

80

35

125

Siphoviridae

H2S

Spherical icosahedron

50

50

200

Siphoviridae

F

Elongated icosahedron

115

65

120

Siphoviridae

H3S

Elongated icosahedron

120

61

138

Siphoviridae

PA1S2 - fl.

Elongated icosahedron

87

41

190

Siphoviridae

D

Elongated icosahedron

94

47

106

Siphoviridae

PAIS2 - med. cl.

Elongated icosahedron

148

74

185

Siphoviridae

V

Spherical icosahedron

56

61

157

Siphoviridae

VIII

Spherical icosahedron

ND

ND

ND

Siphoviridae

H5S

Spherical icosahedron

150

150

225

Siphoviridae

Sigma

Spherical icosahedron

128

109

309

Siphoviridae

HIS

Spherical icosahedron

70

84

40

Podoviridae

E

No evident heads

200-500

Inoviridae?

110

No evident
tails

Tectoviridae?

III

Spherical icosahedron

110
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Figure 3. TEM images of phage are labeled as follows: A, A; B, H3S; and C, H1P. Scale bars are in the bottom black
border, and are 50 nm for A, but 100 nm for H3S and H1P.

A

C

B

Discussion
A total of 32 phage were isolated from 157 sources, suggesting that approximately 20%
of the sources screened could yield phage capable of lysing P. larvae.

While the majority of the

isolated phage were obtained from soil under and around beehives, the proportion of isolated
phage was highest from lysogenic incorporation in strains of P. larvae. However, since a
bacterium is likely to be immune to its own lysogenic phage (Lindahl et al., 1970), as supported
by the host range table of this work, it would be more beneficial to isolate lytic environmental
phage with the broadest host ranges for potential phage therapy. Although the proportion of
positive samples from soil was not as high as some other categories, the soil around beehives is
easily available and was a reliable source of lytic phage that lysed all or nearly all of the 11 P.
larvae strains tested. A higher proportion of phage was isolated from cosmetic samples with beerelated ingredients; however, the use of phage isolated from cosmetic sources might entail legal
ramifications. Phage appear to be present in hives and soil surrounding hives begging the
question of whether they routinely keep P. larvae infections in check until either spore numbers
overwhelm the hive or environmental stressors such as cold winter temperatures make the bees
more susceptible.
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Two potentially different lytic phage were isolated from the same soil sample (PAIS2 fl.
and PAIS2 med. cl.) and two potentially different lysogenic phage were isolated from a single
strain of P. larvae ATCC 49843. After using transmission electron microscopy to visualize the
phage, it is clear that PA1S2 fl. and PA1S2 med. cl. do not have the same phage morphology and,
are therefore, unlikely to be the same phage despite isolation from the same source. As with the
first pair, phage A and E, both lysogenic for ATCC 49843, have different phage morphologies
determined by EM imaging.
Host range experiments were completed to provide information about the ability of the
isolated phage to lyse a broad range of P. larvae strains. However, host range can be affected by
bacterial receptors (Lindberg, 1973). Therefore, host range is not necessarily an indicator of
relatedness, but is useful to determine effective phage for potential AFB treatment. Additionally,
plaque morphology distinguishes phage and enables isolation, but is not a characteristic that
determines relatedness either. Two isolates, IV and VI, have the same spot test lysis pattern when
compared to one another. The plaque morphology of these two isolates is both medium size and
clear, indicating the possibility of these two phage being the same, although they were isolated at
different times from different sources. DNA sequence comparisons of these and the other phage
of interest will need to be made to confirm identity and relatedness. Future work will include
DNA characterization of these isolated phage to determine their relatedness as well as whether a
single phage was isolated several times from various sources across different geographic
locations.
Genersch et al. reclassified the former P. larvae subspecies as P. larvae without
subspecies (2006). Host range data (Figure 1) demonstrated a distinct difference between the two
former Paenibacillus larvae subspecies by susceptibility to P. larvae bacteriophage. Former P.
larvae pulvifaciens (indicated by the numbers 367, 843, 3688, and 368 in the host range table)
have a significantly lower susceptibility to the bacteriophage isolates. P. larvae former
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subspecies larvae is significantly more susceptible to lysis by the isolated phage that P. larvae
former subspecies pulvifaciens and, therefore, it would be beneficial to isolate phage on a former
pulvifaciens strain to ensure effective treatment using a phage cocktail. The fact that there is a
significant difference between the proportion of phage susceptibility with each bacterial (former)
subspecies, indicates the possibility that there are differences between the two former subspecies
not associated with growth or bacterial biochemistry but in biological function in the
environment. It may also be that since the phage were all originally isolated using P. larvae 2605
(previously classified as P. larvae larvae) as the host strain, the phage are more capable of lysing
strains from this subspecies. Additional isolates could be obtained using a strain of P. larvae
former subspecies pulvifaciens to ensure that a cocktail would include phage capable of lysing
such strains, should an AFB diseased hive be infected with P. larvae former subspecies
pulvifaciens.
In the host range results, the lack of clearing on other genera or species other than P.
larvae, indicates high host specificity. As a potential treatment for AFB, such severe host
specificity is encouraging because the microbial ecology of the hive is not well understood, and it
undoubtedly cause problems to harm microbes not intentionally targeted with P. larvae phage. A
spot test should be undertaken in future work to specifically test phage on the individual
microbiota of the natural honeybee microbiota.
By using the most effective phage with the broadest host range on the 11 P. larvae
strains, a cocktail that is capable of lysing 100% of the strains could be created using as few as
the top three isolated phage, H1P, WA, and H1S. A more robust cocktail could be designed by
testing the lysing capabilities of these isolated phage on additional strains of P. larvae. The use
of a cocktail of multiple phage, rather than a single phage, reduces the potential for development
of phage resistance (Dr. Vincent Fischetti, personal communication). Therefore, determining
selection criteria for the most suitable phage is important. If an arbitrary proportion of strains
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lysed is chosen, for example 8 out of the 11, a phage cocktail capable of lysing all 11 strains with
multiple phage capable of infecting each of the strains could be designed using 14 phage.
Determining the effectiveness of a cocktail consisting of the top ranked 4 isolated phage will be
the subject of future work in developing phage therapy as a potential treatment for American
Foulbrood Disease.
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Figure Legends
Table 1. Proportion of samples found to contain P. larvae phage from each category.
Table 2. Sources, descriptions, and current designations of the 32 phage isolates.
Table 3. Morphology of plaques of each phage observed in soft agar overlays. Asterisk* formed
plaques with a turbid halo around a clear plaque center. Sizes ranged and were described using
set plaque diameters in the following classifications: pinpoint (<0.1 mm), small (0.1 mm – 0.5
mm), medium (0.5 mm – 1.0 mm), and large (>1.0 mm).
Figure 1. Host range of 32 isolated P. larvae bacteriophage determined by soft agar overlay spot
tests. Results are interpreted on a scale from no lysis (blank cell) to complete lysis (black cell).
Phage are designated by letters and numbers, corresponding to the source from which they were
isolated.

The bacterial species are represented across the top and are ranked from left to right in

order of susceptibility to lysis by the 32 phage. The isolated phage are listed on the left side of
the table and are ranked from top to bottom in order of the percentage of P. larvae strains they are
capable of lysing. Figure 1 Key. Range of spot test descriptions observed in the host range
experiment. The host range results are interpreted on a scale from no clearing to complete
clearing. Plated examples show representative images of phage lysis on a bacterial lawn.
Figure 2. Proportion of susceptibility to isolated phage of P. larvae strains, which are grouped
by former subspecies. Bacterial strains are listed from back to front.
Table 4. Morphologies of chosen phage determined from TEM images. Images were provided
by the CAMCOR facilities at the University of Oregon. Measurements are based on the averages
of 2-4 images. Question mark indicates uncertainty of classification based on rarity of the family.
Family classifications are based on descriptions of morphology only.
Figure 3. TEM images of phage are labeled as follows: A, A; B, H3S; and C, H1P. Scale bars
are in the bottom black border, and are 50 nm for A, but 100 nm for H3S and H1P.
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CHAPTER 4

EXPERIMENTAL TREATMENT OF APIS MELLIFERA AFFECTED BY AMERICAN
FOULBROOD DISEASE USING PHAGE THERAPY

This chapter is formatted for submission to the Journal of Invertebrate Pathology.
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Abstract
American Foulbrood disease (AFB) is caused by an infection of the bacterium Paenibacillus
larvae in European honeybees, Apis mellifera. Due to the economic and potential environmental
losses of this disease, sustainable treatment regimens should be considered; in particular, phage
therapy, or the therapeutic use of bacteriophage that are capable of lysing P. larvae. Previously
isolated bacteriophage were combined to produce a phage cocktail, then administered to bees
under both of the following conditions: lab-reared honeybee larvae infected with cells and spores
of P. larvae; and a hive infected with AFB located in the state of Washington, USA. The labreared larvae were treated with two different phage cocktails, one with a higher number of phage
types than the other, as both a prophylactic treatment prior to infection with spores and as a postinfection treatment after infection with spores. Results of the lab-reared larval experiments
indicate an increase in survival of infected larvae given phage compared to the survival of
infected larvae without treatment. Results of the field experiment are promising as a preliminary
study on which to base additional treatments, but are inconclusive because of the unavailability of
more than one hive at the time of treatment.

Key words: Paenibacillus larvae, American Foulbrood Disease, bacteriophage, Apis mellifera

Abbreviations
American foulbrood disease (AFB)
Modified brain heart infusion with glucose (GmBHI)
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Graphical Abstract

Introduction (1)
The bacterium, Paenibacillus larvae, causes American Foulbrood disease (AFB), one of
many diseases affecting honeybees, Apis mellifera, (Shimanuki and Knox, 2000). It is recognized
worldwide as an important cause of honeybee death and loss of viable hives (Matheson, 1993;
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Calderone, 2001). This Gram-positive, rod-shaped bacterium produces spores and it was
identified as AFB’s causative agent in 1907(White, 1907) . Adults are resistant to the disease, but
they are vectors that transmit the infective agent (spores) to susceptible larvae (Hitchcock et al.,
1979, Wilson, 1971); the larvae are susceptible during the first 36 h after hatching (Genersch,
2010). In general, spores are resistant to antibiotics, heat and drying, and P. larvae spores in
particular can remain viable for almost four decades (Haseman, 1961). Following a P. larvae
infection that results in the death of one larva, millions of spores can be released in the hive
(Sturtevant, 1932). As the larvae of a hive succumb to the disease, and fewer bees are able to
reach adulthood, the hive collapses as it is unable to maintain its population. These
characteristics make eradication of this disease difficult, and currently, the only viable method for
curing the hive is the direct application of powdered antibiotics , which is not recommended
because antibiotics do not completely eradicate the disease (Calderone, 2001), while an extreme
measure to control the spread of the disease is burning infected hives (Genersch, 2010).
Unfortunately, antibiotic treatment selects for resistant strains of P. larvae (Evans, 2003;Murray
et al., 2007) and is also linked to traces of the antibiotic found in the honey of treated hives
(Oretelli, 2004; Saridaki-Papakonstadinou, 2006). Because of increased resistance and
contaminated commercial products, many countries have ceased antibiotic treatment of AFB
(Chan et al., 2011). Additionally, the burning of hives to prevent spread of the disease results in
significant economic loss to the beekeeping community (Genersch, 2010).

Therefore, the

occurrence and significance of AFB, combined with the lack of safe treatment methods, has
created a need for alternative strategies to address AFB.
A potential method of treatment is phage therapy, or the therapeutic use of bacteriophage
(also called phage) to kill bacterial cells. Phage infect and lyse bacteria (Carlton, 1999), and are
generally specific for target bacterial species. Characteristics of single phage isolated from
lysogenic strains of P. larvae have been explored in previous studies, and several have suggested
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using phage as a potential treatment strategy for AFB (Bakheit and Stahly, 1988; Camana et al.,
1991; Dingman et al., 1984; Drobnikova and Ludvik, 1982; Gochnauer, 1955; Gochnauer, 1970;
Valerianov et al., 1976); however, no significant treatment strategies using phage have been
reported.
Bacteriophage are very abundant in many natural environments (Suttle and Furhman,
2010). Further, they are only self-propagating when host bacteria are present and are very
specific for their host bacterial species. Phage, if used against P. larvae, would decrease the need
for chemical treatment of the hives and would not be harmful to organisms other than their
bacterial host. Therefore, researching the potential use of phage therapy in treating AFB is of
interest for economic and environmental health. Unfortunately, no ready repository of P. larvae
phage is available for use; therefore, various environments were screened for the presence of P.
larvae-specific bacteriophage, phage were isolated and characterized, and further experimental
treatments of infected larvae and an infected hive are described in this study to evaluate the
potential use of phage therapy as a strategy to treat AFB.

Materials and Methods (2)
Bacterial strains and phage isolates (2.1)
The following strains of P. larvae were used: NRRL B-2605, NRRL B-3554, NRRL B3650, ATCC-25748, ATCC-25747, ATCC-49843, ATCC-25367, ATCC-25368, ATCC-3688. In
addition, two naturally occurring cultures isolated from infected hives were used: 2188 and 2231.
Bacterial cultures were grown with the same media and under the same conditions described in
the phage isolation methods from Alvarado et al. (2014) (submitted). The phage used in this
research had been previously isolated as described in Alvardo et al. (2014) (submitted) and were
selected from a pool of 32 total isolates based on the broadest host range of P. larvae strains
(Yost and Amy, 2014) (unpublished data).
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Amplification and quantification of phage titers (2.2)
Phage isolates were amplified prior to use in the experimental treatments. The
procedures for amplification and quantification of phage titers were the same as those described
by Alvarado et al. (2014) (submitted).
Larvae experiments (2.3)
Bacterial cell and spore harvesting (2.3.1): Eleven strains of Paenibacillus larvae were
grown in 20 ml of GmBHI at 37 °C and shaking at 100 rpm. After overnight incubation, the
turbid culture was pelleted by centrifugation, the supernatant discarded, and the cells resuspended
in 200 µl sterile GmBHI broth. The concentrated cells were plated in serial dilutions using
GmBHI agar plates and GmBHI sterile broth dilution blanks, and then colonies were counted to
determine the colony forming units (CFU) of the concentrate. A volume of 200 µl of the
concentrate was added to 1 ml of prepared larvae food, resulting in a titer of 10 5 cells per total
volume. Food was mixed by vortexing, then fed to larvae on a daily basis. New food was
prepared with freshly grown bacterial cultures daily. Approximate numbers of CFUs being fed to
each larva were calculated according to the final titers in the larvae food and amount of food fed
to each larva per day (Table 1). Spores were prepared by first inducing sporulation then
harvesting spores as described by the spore methods in Alvarado et al. (2014, submitted) with the
exception of replacing the HistoDenz (Sigma) density gradient with d-Sorbitol of the same
concentrations. Spore concentration was calculated by serial dilution and plating of the final
product. Calculations of spore load fed to each larva per day are given in Table 1.
Phage cocktail preparation (2.3.2): Titers per ml of the amplified single phage lysates
were determined as previously described and are as follows: H1P, 5 x 10 4; WA, 3 x 106; F, 5 x
106; V, 4 x 105; H2S, 104; H3S, 4 x 105; XIII, 4 x 106; E, 104; H5S, 9 x 103; VII, 2 x 106; D, 106;
PAIS2 fl, 9 x 102; and B, 5 x 106. Two separate cocktails were made, the first (phage cocktail #1
or PC1) containing the following 7 phage: H1P, WA, F, V, H2S, H3S, and XIII; and the second
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(phage cocktail #2 or PC2) containing all 13 phage; however, in both cases the final titer of
combined phage was approximately the same (phage cocktail #1, 1.8 x 106; phage cocktail #2, 1.6
x 106). Phage cocktail makeup was determined based on host range capabilities, and represents
the broadest range of lysing capability on 11 different strains of P. larvae (Chapter 3). A volume
of 1 ml of each lysate was combined for the final phage cocktail. The final phage concentration
was both calculated from initial titers and confirmed by soft agar overlay platings done in serial
dilution after combination. A volume of 200 µL of each cocktail was added to 1 ml of prepared
larvae food prior to feeding to larvae. Calculated PFUs fed to each larva per day are listed in
Table 1.

Table 1 Volumes of food and titers of phage, bacteria and spores fed to larvae daily.
Days after Grafting

Day 0

Day 1

Day 2

Day 3

Day 4

Day 5

Day 6

Day 7

Day 8

Volume of Larvae
Food (µl)

10

10

20

30

40

50

50

60

0

Calculated # of CFUs
(any strain)

800

800

1600

2400

3200

4000

4000

4800

0

Calculated # ATCC
49843 Spores

100

100

200

300

400

500

500

600

0

Calculated # NRRL
B-3554 Spores

90

90

180

270

360

450

450

540

0

Calculated # Isolated
2188 Spores

90

90

180

270

360

450

450

540

0

Calculated Number
of PFUs in PC1

3.003

3.003

6.003

9.003

1.204

1.504

1.504

1.804

0

Calculated Number
of PFUs in PC2

2.673

2.673

5.333

8.003

1.074

1.334

1.334

1.604

0

Larvae food preparation and treatment (2.3.3): Larvae food consisted of the following:
14.4 ml sterile, distilled water, 4.2 g royal jelly powder (Glory Bee), 0.6 g glucose (Difco), 0.6 g
fructose (Difco), and 0.2 g yeast extract (Difco) as described by Peng et al. (1992). The sugars
and yeast extract were added to the water, this mixture was filtered, and then UV treated for 1 h.
The royal jelly powder (4.2 g) was aseptically added to the water mixture but was otherwise
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untreated. The mixture was made homogenous by vortexing to ensure complete dispersion of the
royal jelly. Food was prepared and stored at -20 °C until needed. Larvae were fed increasing
amounts of food each day (Crailsheim et al., 2012), as indicated in Table 1. As a negative
control, larvae were fed larvae food without amendments while all other larvae were fed a
mixture of food with treatment additives. In each case, 200 µL of concentrated spores, cells, or
phage cocktails were added to 1 ml of larvae food as described above. Larvae were given the
following treatments: negative control = food with no additives, broth control = food with
GmBHI broth added to the same dilution as other additives, water control = food amended with
200 ul sterile water, food containing NRRL B-3554 vegetative cells, food amended with ATCC
49843 vegetative cells, food amended with isolated 2188 vegetative cells, food amended with
NRRL B-3554 spores, food amended with ATCC 49843 spores, food amended with 2188 spores,
prophylactic phage therapy treatments and post-infection phage therapy treatments (food
amended with 200 ul phage cocktail #1 or #2). All larvae in the experimental phage cocktail
treatments were infected with spores from P. larvae 2188. Two phage cocktails, phage cocktail
#1 and phage cocktail #2 were tested in both the prophylactic and post-infection treatment
experiments.
Larvae rearing (2.3.4): Larvae were reared by methods similar to those described by
Crailsheim et al. (2012). Queens were caged using plastic or metal wire mesh approximately one
week prior to the intended date of grafting larvae. While the queens were confined, the age and
location of larvae in the frame were ensured. Eggs, turned to a horizontal position shortly before
hatching, were then closely observed and the hatched larvae were grafted from the frames within
a day after hatching. Each treatment included a corresponding negative control consisting of
larvae taken from the same frame on the same day. Preliminary experiments were conducted by
placing the grafted larvae into 96-well plates, but later were conducted by placing grafted larvae
into sterile petri dishes (VWR) because survival rates were higher in larvae reared with more
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space. It appeared that higher survival rates were observed because the larvae food was not
confined leading to a lower chance of larval drowning. Incubation microcosms were created by
placing 1 L of 10% glycerol in the bottom of plastic containers followed by a layer of plastic
support on which sat the well plates or petri dishes. The boxes were closed with loosely fitting
plastic lids, this allowed the humidity to be maintained at 90% within the microcosms. Metal
trays filled with water were placed on the bottom of the incubator to maintain humidity within the
incubator’s interior at 80%. The temperature was kept at 34 °C. Larvae were fed daily with the
amount of food indicated in Table 1. On the eighth day after grafting, larvae were removed from
the petri dishes and placed on sterile filter paper in new petri dishes outside the microcosms for
pupation.
For the larvae controls, larvae were fed either unamended food, food diluted with
GmBHI, or food diluted with water (Figure 1). The negative control data represent 3 replicates
with n=20, 21, and 15, the GmBHI data represent 2 replicates with n=20 each, and the water
data represents 2 replicates with n=22 and 21.
Each experimental treatment also had a corresponding negative control prepared on the
same day from the same frame and fed unamended food. Negative control data for Figures 2-6
represent the average of 10 control replicates with n=12 or 13. The average of all negative
controls was determined rather than using individual negative controls because of the small
sample sizes, which were limited due to the number of larvae in the hives. During the vegetative
cell infection treatments, two replicates for each strain with samples sizes from 32 to 49 (mean
size of 45 larvae) were prepared.
Larvae were fed ATCC 49843 and NRRL B-3554 spores daily. Two different treatments
with 2188 spores were conducted; one in which larvae were fed spores daily and one in which
only one dose of spores was administered on the first day. Spore treatment sample sizes ranged
from 48-53 with a mean size of 50 and all spore infection treatments were conducted in duplicate.
61

Phage preparations were administered to larvae by adding the phage cocktails suspended
in GmBHI to the larvae food (as previously described). Phage cocktail experiments were
conducted in duplicate and all phage cocktail treatments ranged from 48- 55 with a mean value of
51. Disparate sample sizes were due to larvae available to graft on any given day.
Daily observations (2.3.5): Larvae were viewed under a dissecting microscope (Nikon)
daily and observed for signs of life: opening and closing spiracles or food consumption. In the
event that no movement could be seen for the first 2 days, larvae were kept until day 3 in the
event that larvae were alive but not producing easily visualized movement. On the third day, if
no growth or movement was observed, larvae were assumed dead and removed. Samples of dead
larvae were kept at -20 C in 20% glycerol stocks for PCR analysis in order to determine presence
of bacterial DNA. The number of surviving larvae was recorded daily.
Field experiment (2.4)
Lyophilization of phage cocktails (2.4.1): Between 10 and 15 ml of individual amplified
phage lysates were lyophilized separately (LabConco Lyophilizer). Samples were allowed to
completely dry overnight; once all liquid was removed, samples were weighed and equal amounts
(0.02 g) of each powdered phage preparation was combined. This powdered mixture was easily
transported to the field site. Experiments to ensure phage viability after lyophilization were
conducted with reconstituted the lyophilized phage. Powdered phage mixtures were resuspended
in either water or sugar syrup (8.75 g sucrose/10 ml water) and plated to determine phage
viability in diluents proposed for field study.
Field resuspension of phage and spray treatment on hives (2.4.2): Lyophilized phage
preparations were taken to the field site near Bellingham, WA, reconstituted with 10 ml of water,
and then poured into 400 ml of sugar syrup. After shaking to homogenize the mixture, the entire
volume was sprayed directly on alternating frames in the infected beehive. The following day,
the sugar syrup mixture had been cleaned by the nurse bees and was no longer visible.
62

Treatments occurred on 6/26, 6/28, 7/10, 7/23, and 8/6 in the summer of 2013. The first two
treatments were administered in the presence of the beekeeper and the remaining three were
conducted by the beekeeper. On each date, either odd or even numbered frames were sprayed
with the sugar syrup/phage preparation.
Hive observations (2.4.3): Frames were selected on the first treatment day for qualitative
visualization of the extent of the infection and were photographed on the first day as well as at
each subsequent treatment. Gross comparisons of the frames were made over time, but detailed
results were difficult to determine based on visualizations only. Additionally, the beekeeper
reported the general state of the treated hive on a regular basis until the end of the treatments.
Post-treatment actions and related observations (2.4.4): One month after the last phage
treatment was administered, the beekeeper removed the worst of the diseased frames and replaced
them with fresh, uninfected, and unpopulated frames. By October 11, 2013, the beekeeper
reported no evidence of AFB in the hive, and as of January 2014, no recurrence has been
reported.
Statistical analysis (2.5)
Student T tests were performed on all treatments and controls to determine the statistical
significance of their comparisons. A significance value of α > 0.05 was used throughout this
study.

Results (3)
Lab experiments (3.1)
Results obtained from the control experiments are shown in Figure 1. There is a
significant difference between both the survival of the negative control and the water control
(p=0.002) and between the GmBHI broth control and the water control (p=0.034), but not
between the negative control and the GmBHI broth control (p=0.347).
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Figure 1 Larvae Survival - Controls. Displays the mean proportion of larvae survival from the following treatments:
negative control, food with GmBHI added, and food with water added. Error bars represent the standard deviation.
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Results from the vegetative cell infection treatments are shown in Figure 2. There is a
significant difference in the larvae survival by day 8 between the negative control larvae and
those infected with P. larvae ATCC 49843 (p=0.000548) as well as between the negative control
larvae and those infected with P. larvae 2188 (p=0.00560) but not with larvae infected with
NRRL B-3554 vegetative cells (p=0.139). The larvae infected with NRRL B-3554 that survived
until pupation were incubated until pupation was complete, and the body mass was recorded for
each fully pupated bee. Compared to the control bees, the mass of the infected bees was
significantly lower (p=0.0035).
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Figure 2 Larvae Survival with Vegetative Cell Infections. Larvae infected with vegetative cells from P. larvae
ATCC 49843, NRRL B-3554, and isolated 2188. Error bars represent the standard deviation.
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Spore infection experiments indicate a significant decrease in survival of larvae infected
with spores from any of the three bacterial strains compared to the control (Figure 3). There is a
significant difference between the survival rates of the larvae infected with any of the spores and
the negative control larvae ATTC 49843 (p=1.99E-8; NRRL B-3554 (p=1.79E-8) and the one
dose spore infection with 2188 (p=4.97E-7) ; however, there is not a significant difference in the
survival rates of larvae fed only one dose of 2188 spores when compared to larvae fed daily doses
of 2188 spores (p=0.102).
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Figure 3 Larvae Survival of Spore Infections. Data represent the proportion of surviving larvae after infection with
P. larvae spores from the following strains: ATCC 49843, NRRL B-3554, and isolated 2188. Two infections using
spores from 2188 were conducted; one with daily doses of spores and one with a single dose on the first day. Error
bars represent the standard deviation.
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T-test comparisons between the larvae fed spores (Figure 3) or vegetative cells (Figure 2)
of the same strains yield the following: the ATCC 49843 vegetative cells compared to spore
infection , p=0.010; the NRRL B-3554 vegetative cells compared to spore infection, p=0.002; the
2188 vegetative cells compared to the 1-dose spore infection, p=0.384. There is a significant
difference between the survival rates of larvae infected with spores of either ATCC 49843 or
NRRL B-3554 compared to larvae infected with vegetative cells of the same strains. There is not,
however, a significant difference between the survival rates of larvae by day 8 between those
infected with spores or vegetative cells of 2188.
Results from phage cocktail #1 experiments are shown in Figure 4. There is not a
statistically significant difference between the negative control and phage cocktail #1 control (
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p=0.077). There is a significant difference between the survival of larvae given phage cocktail
versus infected with spores of 2188(p=0.045). There is also a significant difference in survival
rates between both forms of phage treatment (either administered prior to (p=0.010) or after
(p=0.031) infection) and infected larvae without treatment, but not between the survival of the
treatments themselves (p=0.293).

Figure 4 Larvae Survival of Phage Cocktail #1 Treatments. Phage cocktail #1 treatments. Larvae were fed spores,
phage cocktail, spores and then phage cocktail, or phage and then spores. Error bars represent the standard deviation.
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Results from the phage cocktail #2 experiments are shown in Figure 5. Assuming  <
0.05, there is a significant difference between the phage cocktail #2 larvae and the infection
control (p=0.002), but not between the phage cocktail #1 larvae and the negative control
(p=0.069). There is not a significant difference between the infection control and the treatment
regimen (p=0.271), but there is a significant difference between the infection control and the
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prophylaxis regimens (p=0.024). The decrease in survival is most likely due to compromised
larvae that were grafted on that day, as the corresponding negative control larvae had a much
lower survival than the overall average of all of the negative control experiments. There is a
significant difference between the prophylaxis and the treatment regimens using phage cocktail
#2 (p=0.044). The survival of larvae treated with the phage cocktail prior to infection increased
by 70%, and was comparable with the survival rates of the phage cocktail controls.
Figure 5 Larvae Survival of Phage Cocktail #2 Treatments. Data represents experiments with phage cocktail #2
treatments. Larvae were fed spores, phage cocktail, spores and then phage, or phage and then spores. Error bars
represent standard deviation.
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The efficacy of the two different phage cocktails is determined by comparing the data
represented in Figure 4 and Figure 5. T-test comparisons yield the following: comparison
between the prophylaxis treatment of phage cocktail #1 and phage cocktail #2, p=0.162; and
comparison between the treatment regimen of phage cocktail #1 and phage cocktail #2, p=0.041.

68

Assuming  < 0.05, there is a significant difference between the different phage cocktails when
used as a treatment, but not when used as a prophylaxis.
Figure 6 displays the proportion of deceased larvae that tested positive for P. larvae DNA
by PCR and gel electrophoresis (Piccini et al., 2002). Larvae obtained from negative control and
phage cocktail control experiments (both of which had no bacteria added) showed no evidence of
P. larvae DNA. Approximately 40% of the larvae taken from vegetative cell experiments were
positive for DNA. Approximately 25% of the larvae taken from spore experiments were positive
for DNA. The average proportion of larvae positive for P. larvae DNA from phage cocktail
treatments, regardless of whether phage was administered prior to or after spore infection, was
slightly lower at 20%.

Figure 6 Samples Positive for P. larvae DNA Detected Using PCR and Gel Electrophoresis. The proportion of
deceased larvae positive for P. larvae DNA identified by P. larvae-specific primers and gel electrophoresis.
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Field experiment (3.2)
Experiments to determine phage viability after lyophilization were conducted to
determine whether powered phage lysates were a practical option to use in a field setting. Prior to
lyophilization, the average titer of multiple phage lysates was approximately 10 8/ml. After
lyophilization, the cocktails were resuspended in either sugar syrup or sterile water and the
average of the resuspended cocktails was approximately 105/ml. The resuspended phage
cocktails were maintained at 4 °C for one month, then titers were determined to be approximately
104/ml.
Pictures were taken of the same frames each time a treatment occurred, and observations
were determined by the beekeeper. Pictures revealed a slight visual improvement during the
treatment process, but not a complete eradication of the disease. The comb was both darker and
has more sunken capped cells (both characteristics of AFB) in the image taken on the first day of
treatment. The beekeeper reported removing the diseased frames and replacing them with virgin,
unpopulated frames after treatments had ended. Four months after the initial treatment, the
beekeeper reported no visible sign of infection (Karen Bean, personal communication).
Samples were obtained after the treatment regimen ceased, and the procedures to isolate
phage as previously described (Chapter 2) were conducted. It was determined that the phage
from the administered phage cocktails were present in the hive after the 5 treatments had ended.

Discussion (4)
Lab experiments (4.1)
Results from the control experiments (Figure 1) indicate that dilution of the larvae food
with water decreases the nutrients to the point of starvation, leading to significant larval death
after four days of incubation. However, when GmBHI broth is used to dilute food, no significant
decrease in larval survival was observed, possibly due to the addition of the nutrients in the
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medium. This preliminary experiment is important because phage, spores, and vegetative cells
were added to the larvae food in GmBHI broth.
Vegetative cell infection experiments (Figure 2) indicate that the survival of larvae
infected with strains 2188 or ATCC 49843 resulted in similar low survival by the 8 th day;
however, infection with ATCC 49843 rapidly decreased larval survival by the first day after
grafting. Although the disease is transmitted by spores (Genersch, 2010) and previous work
suggests that vegetative cells do not cause AFB in larvae (Tarr, 1937), our results showing the
significant decrease in survival of larvae infected with vegetative cells of strains 2188 or ATCC
49843 compared to the negative control indicate that the vegetative cell of P. larvae is also an
infective agent. Additionally, although the larvae infected with NRRL B-3554 maintained
viability until they entered pupation, the size and weight of the pupae after pupation were
significantly smaller than that of the negative control. This indicates the possibility that although
bees survived infection with vegetative cells, their development was compromised and begs the
question of whether these smaller bees would even be accepted within the hive.
There was a significant decrease in survival of larvae infected with spores from any of
the three bacterial strains compared to the control (Figure 3), which is consistent with previous
literature (Tarr, 1937; Toumanoff, 1929; Woodrow, 1941; Woodrow, 1942;). The results also
demonstrate that there is not a significant difference between the proportion of larval survival
when infected with one dose of spores on the first day compared to comparable doses
administered each day with the same strain (2188). This indicates a single exposure of P. larvae
spores causes the same mortality as multiple exposures, which supports the claim that low doses
of spores can cause infection of AFB in honeybee larvae (Woodrow, 1942).
Comparisons between data represented in Figures2 and 3 indicate that the efficacy of
spores in reducing larval survival is greater than that of the vegetative cells. However, as
previously stated, vegetative cells can also decrease larval survival as well as inhibit their
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development. This is demonstrated by the similar decreases in survival of larvae infected with
spores or vegetative cells of 2188 and by the significantly lower body masses of the fully pupated
bees infected with NRRL B-3554.
The phage cocktail #1 control displays a small but insignificant decrease in survival
compared to negative controls (Figure 4). In each case using phage cocktail #1, whether
administered prior to or following infection with 2188 spores, the larval survival was higher than
the untreated infected larvae. Although the survival of larvae under both treatment regimens
were significantly lower than the survival of the negative controls, they were also significantly
higher than the survival of the larvae infected with spores without treatment. This indicates that
the addition of phage cocktail #1 decreased mortality of infected larvae and might potentially be
used in prophylaxis or treatment of AFB. The phage cocktail #2 control displays a small but
insignificant decrease in survival compared to negative control (Figure 5). The prophylactic
treatment using phage cocktail #2 increases survival above the infected larvae with no treatment,
indicating it also might be an effective prophylaxis for AFB.
Results of the PCR and gel electrophoresis experiments demonstrate that there was not
cross contamination of samples during preparation nor incubation as none of the samples tested
that had not received bacteria showed evidence of bacterial DNA (Figure 6). The presence of
bacterial DNA in the dead larvae from the vegetative cell experiments suggests that they likely
died from a P. larvae infection. The low percentage (40%) could be indicative of interference
with the PCR process because 100% of the larvae were fed bacterial cells. It is likely that larvae
positive for P. larvae DNA taken from the spore infections also died from a P. larvae infection.
The lower proportion of deceased larvae from phage-treated infected specimens that were
positive for P. larvae DNA is consistent with treated larvae having a lower mortality rate than
untreated infected larvae.
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Field experiment (4.2)
The opportunity to treat an infected hive presented itself when a beekeeper in the state of
Washington, USA, contacted UNLV with questions regarding AFB. She had previous experience
dealing with multiple AFB-infected hives, and at the time of contact, had one infected hive. The
beekeeper was willing to allow an experimental treatment on her infected hive, and this was
undertaken. As such, the results of this study should only be considered as preliminary with clear
necessity to carry out further field testing on more hives in the future. Additionally, as the hive
was already infected, the study is a post-infection treatment experiment only. It was not deemed
ethical to administer phage to a healthy hive prior to purposefully infecting it with P. larvae, so a
prophylactic treatment regimen was not conducted outside of the lab.
Planning included preparation of phage cocktails by lyophilization for the field
experiment, which was a convenient method to store and transport phage. Some loss of phage
viability during the lyophilization and reconstitution procedures occurred as seen by reduced
phage titers throughout the process. However, enough phage survived to use as a starting material
for treatment of the infected hive. Using a phage cocktail with a larger concentration prior to
lyophilization would allow for a higher starting titer and perhaps more effective treatment of the
hive. The resuspended phage cocktails were maintained at 4 °C for one month, then titers were
determined to be approximate 104, a loss of only10 fold during that time. This indicates the
lasting viability of resuspended, previously lyophilized phage in diluted form and is consistent
with long-term storage of phage lysates at either 4 C or at 37 C (data not shown).
Throughout the treatments, the infected hive improved but the disease was not eradicated.
This could be because of, among other potential reasons, the severity of the disease in that hive,
the need for a higher starting titer of phage cocktail, or the inability of phage to infect spores of P.
larvae. A combination of a spore germinant administered prior to phage treatment with a higher
concentration of phage could be tested for effectiveness . Although the disease was not
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eradicated immediately after treatments, the beekeeper reported that at four months after the first
treatment (late October 2013) there was no evidence of AFB in the treated hive, and no
recurrence of the disease has been reported as of January 2014. These results are based on the
observations of the beekeeper, who is familiar with symptoms of AFB, and interpretation of the
pictures of hive frames. However, the lack of recurrence of AFB in the hive could be due to the
removal of the infected frames by the beekeeper, the addition of the phage cocktail into the hive,
or a combination of both. More infected hives should be experimentally treated with phage
cocktails to make this determination.

Conclusions (5)
The results of the lab experiments indicate an overall improvement in survival when
phage cocktails are administered to infected larvae. Prophylactic treatment with phage cocktail
#1 is slightly more effective than the post infection treatment, although not significantly so, while
prophylactic treatment with phage cocktail #2 is significantly more effective at increasing larval
survival than post-infection treatment. This indicates a prophylactic regimen may be more
effective at preventing the disease than a post-infection treatment once a hive was already
infected.
The higher survival of larvae that underwent prophylactic treatment with phage cocktail
#2 than with phage cocktail #1 indicates that a cocktail with a greater number of different phage
is more effective than a cocktail with fewer different phage.
The slightly decreased survival, although not significantly so, of the larvae given food
diluted with phage cocktails may be due to the same reason larvae survival is slightly decreased
when fed larvae food diluted with GmBHI broth. Experiments should be conducted to add more
highly concentrated phage without diluting the food as much and maintaining the same
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consistency as the negative control food to ensure that larval death is a result of the food dilution
and not of the phage cocktails themselves.
Only one hive was experimentally treated in the field, and confident conclusions cannot
be reasonably drawn. However, the fact that the hive has had no recurrence of AFB is
promising. More experiments should be conducted to determine whether the apparent
disappearance of the disease is the result of phage treatment, the removal of infected frames, or a
combination of both. Prophylactic phage treatments on hives in a more natural setting would be
useful, but would have to be undertaken careful control to ensure accidental spread of AFB after
purposeful infection of an experimental hive would not occur.
The results from these preliminary experiments indicate using phage therapy is a
potential option to treat American Foulbrood disease.
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Figure Legends
Table 1 Volumes of food and titers of phage, bacteria and spores fed to larvae daily.
Figure 1 Larvae Survival - Controls. Displays the mean proportion of larvae survival from the
following treatments: negative control, food with GmBHI added, and food with water added.
Error bars represent the standard deviation.
Figure 2 Larvae Survival with Vegetative Cell Infections. Larvae infected with vegetative
cells from P. larvae ATCC 49843, NRRL B-3554, and isolated 2188. Error bars represent the
standard deviation.
Figure 3 Larvae Survival of Spore Infections. Data represent the proportion of surviving
larvae after infection with P. larvae spores from the following strains: ATCC 49843, NRRL B3554, and isolated 2188. Two infections using spores from 2188 were conducted; one with daily
doses of spores and one with a single dose on the first day. Error bars represent the standard
deviation.
Figure 4 Larvae Survival of Phage Cocktail #1 Treatments. Phage cocktail #1 treatments.
Larvae were fed spores, phage cocktail, spores and then phage cocktail, or phage and then spores.
Error bars represent the standard deviation.
Figure 5 Larvae Survival of Phage Cocktail #2 Treatments. Data represents experiments with
phage cocktail #2 treatments. Larvae were fed spores, phage cocktail, spores and then phage, or
phage and then spores. Error bars represent standard deviation.
Figure 6 Samples Positive for P. larvae DNA Detected Using PCR and Gel Electrophoresis.
The proportion of deceased larvae positive for P. larvae DNA identified by P. larvae-specific
primers and gel electrophoresis.
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CHAPTER 5

GENERAL DISCUSSION
The importance of the European honeybee, Apis mellifera, to agriculture, the economy,
and environmental health are reasons to consider the overall well-being of the organism,
especially when reflecting upon recent declines in honeybee populations (VanEngelsdorp et al.,
2013; Charles, 2013). A major contributing factor to poor honeybee health is American
Foulbrood disease (AFB) (Genersch, 2010), which is caused by the pathogen, Paenibacillus
larvae, a gram-positive, spore-forming bacterium. Extreme, destructive methods, such as burning
hives and equipment, to prevent the spread of the disease coupled with the problems associated
with antibiotic use for treating AFB, including increased bacterial resistance and contaminated
honey, are reasons to consider research into alternate methods of treatment.
For example, phage therapy is an alternative to antibiotics in human medicine (Fischetti
et al., 2006), and has been proposed as an alternative for treatment of animal diseases, including
AFB (Gochnauer, 1955; Gochnauer, 1970; Drobnikova and Ludvik, 1982, Popova et al., 1976;
Valerianov et al., 1976; Dingman et al., 1984; Bakheit and Stahly, 1988; Campana et al., 1991).
Phage therapy, or the therapeutic use of bacteriophage to target specific bacterial pathogens,
would require phage that use the pathogen of AFB, Paenibacillus larvae, as its host. The work
presented here considered the development of methods to isolate such bacteriophage, the ease of
obtaining P. larvae phage, phage characterization and selection for further research, and finally,
the efficacy of phage cocktails in treating infected larvae and an infected beehive.
Bacteriophage are extremely abundant in nature (Suttle and Fuhrman, 2010), and as such,
phage capable of lysing P. larvae strains should exist in nature and isolation of such
bacteriophage should be feasible. Isolation of phage required acquisition of samples, enrichment
with P. larvae NRRL B 2605 to allow propagation of phage capable of lysing the pathogen,
77

screening of each sample for bacteriophage, isolation to obtain pure phage lysates, and
amplification of isolated phage (Chapter 2). After screening 157 samples for phage capable of
lysing P. larvae, 32 phage isolates were found (20%). Completion of the environmental
screening revealed that P. larvae phage are abundant in easily accessible environmental sources
and can be successfully isolated. Such ease of acquiring the phage would be useful to obtain
more phage should future researchers decide to pursue phage therapy as an option for AFB
treatment.
Chapter 3 reviewed the sources and characterization of the isolated P. larvae phage. The
majority of the isolated phage were obtained from soil under and around beehives, as indicated by
the results outlined in Chapter 3, and lytic environmental phage with broad host ranges on many
P. larvae strains have potential for phage therapy. The soil around beehives is easily available
and was a reliable source of lytic phage that lysed all or nearly all of the 11 P. larvae strains
tested.
The lack of lysis of other genera and only one incidence of slight clearing on a
Paenibacillus sp. indicates high host specificity. This is encouraging because it would be
undesirable to cause lysis of bacterial species other than the targeted pathogen. This is also
important since the natural microbiota is often necessary to maintain both bee gut health and the
overall health of the hive (Olosfsson and Vásquez, 2008).
It was not known whether the 32 isolated phage represented one phage type isolated 32
times, 32 different phage, or some combination of isolation of identical phage and new ones from
different samples. The phage isolated in this study were characterized by plaque morphology,
host range on various bacterial species and by electron microscopy. Since host range can be
affected by bacterial receptors (Lindberg, 1973), it is not a very reliable indicator of relatedness,
but it is useful to choose effective phage for potential AFB treatment. DNA sequence
comparisons of the phage of interest has begun and will need to be further investigated to confirm
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identity and relatedness. The methods described in Appendix A outline the procedures required
for isolating and purifying the phage DNA. In addition to bacterial species host range data, there
is a significant difference between the susceptibility of two former subspecies of P. larvae, larvae
and pulvifaciens, to the isolated bacteriophage. The phage isolated using as a host a former P.
larvae larvae strain had a greater success rate in lysing bacterial strains of that former subspecies
compared to the P. larvae pulvifaciens strains. Despite the reclassification of these two former
subspecies into a single species without subspecies (Genersch et al., 2006), this could indicate
differences between the two former subspecies that are potentially distinct enough to reconsider
classification. Even if this is not considered, it should be pointed out that in order to create a
phage cocktail fully capable of efficiently infecting a broad host range of all P. larvae strains that
cause AFB, phage isolated by enriching samples with former P. larvae pulvifaciens would ensure
a more robust cocktail.
The characterization of the isolates in Chapter 3 led to the selection of specific phage for
use in both lab and field experimental treatments. Chapter 4 describes the protocols used to
determine the efficacy of the selected phage as a phage therapy treatment regimen for infected
larvae and an infected hive.
An increase in survival of larvae was observed when phage were administered in
conjunction with spore infection compared to spore infection alone (Chapter 4). Dilution of food
with water decreased survival of larvae significantly, while dilution of food with media that
contained considerable nutrients (GmBHI) decreased survival slightly but not significantly,
indicating future experimental design should concentrate any food additives in order to avoid
dilution.
Results from experiments feeding vegetative cells to larvae indicate that although
mortality was not as high as when larvae are fed spores of the same bacterial strain, there is a
significant decrease in survival compared to the negative control for at least two of the strains
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tested. Additionally, the strain that did not significantly decrease larvae survival did significantly
decrease adult bee body mass after pupation, indicating that although they survived, the larval
development was compromised. Comparison of data from vegetative cell infections and spore
infections indicate that the efficacy of spores in reducing larval survival is considerably greater.
Spore infection experiments indicate a single dose of spores (# of spores) is sufficient to cause a
significant decrease in survival of larvae.
Use of phage cocktails (combinations of those phage that can effectively lyse the
broadest range of P. larvae strains) in larvae infected with P. larvae spores increased survival in
comparison to the larvae infected with spores only, with the exception of the post-infection
treatment which had a corresponding negative control with a low survival. This suggests the
ingestion of phage either before or after infection with P. larvae spores is beneficial to the
survival of the larvae. In particular, the larvae given phage cocktail #2 prior to infection
maintained survival so dramatically that it was statistically insignificant from larvae survival in
the phage cocktail #2 control. These experiments need to be repeated to affirm their validity.
When the opportunity to treat an infected hive presented itself, an experiment was
designed around field practicality to administer a phage cocktail. Through experimentation, it
was determined that lyophilization is a feasible way to preserve phage in a convenient form, and
that phage retain most of their viability through this process. A high starting phage titer would
ensure that the loss of phage viability seen through lyophilization would not be too great as to
diminish the effectiveness of the treatment. Although complete eradication of AFB was not
witnessed throughout the duration of the field treatment, the hive was reported to be clear of signs
of the disease four months after the initial dose of phage was administered, and reoccurrence has
not been reported. However, since the beekeeper removed the hive frames with the most severe
symptoms, whether the lack of disease is due to the phage, the frame removal, or a combination
of both is uncertain at this time. Additional research should be conducted to determine this
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question. As such, this study should only be considered a preliminary experiment conducted as a
precursor to testing on a larger scale in the future. Furthermore, only one hive was available for
this experimental treatment, but should additional infected hives become available for testing,
supplementary experiments should be conducted.
The body of this work describes methods to acquire pure isolates of phage capable of
lysing P. larvae, the causative agent of AFB. Such phage, when combined, are useful to increase
the survival of larvae infected with the pathogen under lab conditions, and potentially to help
alleviate the disease in the field. Although more experimental field and lab treatments should be
conducted, results from the experiments presented here suggest phage therapy is a viable
treatment option to of American Foulbrood disease.
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APPENDIX A

DNA ISOLATION, CHARACTERIZATION, AND SEQUENCE COMPARISON OF
ISOLATED BACTERIOPHAGE CAPABLE OF INFECTING THE CAUSATIVE AGENT OF
AMERICAN FOULBROOD DISEASE, PAENIBACILLUS LARVAE

FORWARD
The following methods described were those used to prepare phage isolates for DNA
analysis. Preparation from raw samples was completed by Diane Yost. After DNA samples were
amplified with Phi29 polymerase, they were sent to Andrew Krohn at Northern Arizona
University for sequencing procedures. Raw sequence data was analyzed by Philippos Tsourkas.
Results are still being fully analyzed and as such, are not presented here.

Materials and Methods
Amplification of Isolated Bacteriophage.
Previous studies were conducted to isolate bacteriophage that are capable of lysing strains
of Paenibacillus larvae from environmental and commercial sources (Chapter 2 and 3). Based on
characterizations conducted that were described in Chapter 3, 18 isolates were chosen for further
DNA characterization. Bacteriophage lysates were prepared by inoculation of 50 ml log phase
bacterial cultures of Paenibacillus larvae 2605 (NRRL) with 1 ml of individual phage isolates
and shaking at 100 rpm and 37 °C overnight. Following centrifugation (3220 x g for 10 min), the
lysates were filter sterilized using 0.45 um sterile cellulose nitrate filter cartridges (VWR) to
remove bacterial cells and debris. This lysate was used to prepare a highly concentrated phage
lysate by plating 20 identical soft agar overlay plates. P. larvae strain 2605 was mixed with each
isolate with sufficient phage to result in complete lysis of bacterial cells. Plates were prepared
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with GmBHI (0.4% Difco glucose was added to mBHI) containing 1.5% agarose and overlays
were made of GmBHI with 0.95% agarose. These plates were incubated overnight at 37 °C
(NapCo E Series Model 303 Incubator). Five ml of PBS pH 7.1 was added to the surface of each
plate and was allowed to sit for 20 minutes. The top layer of the agarose overlay was then
scraped off using a sterile pipette tip, making sure the underlying medium was not disturbed. The
scraped agarose plus PBS was collected and transferred to a funnel lined with four layers of
cheesecloth to remove the agarose particles. The resulting liquid was then filtered through a
sterile 0.2 µm filter (Sartorus) using vacuum filtration to remove bacterial cells.
Phage DNA Precipitation and Resuspension
The filtrates described above were poured into sterile 50 mL polysulfone centrifuge tubes
(Thermo Scientific) and phage were pelleted by centrifugation for 15 hours at 4 °C and 18,000 x
g (Beckman J2-HS). The supernatant was carefully decanted from the phage pellet (a thin,
transparent film), the tubes were inverted and then allowed to drain for 1-2 minutes but not
allowed to completely dry. The phage pellet was gently resuspended in 1.0 ml of phage buffer,
pH 7.5 with a composition of 10 mM Tris-HCl, 10 mM MgSO4, and 68 mM NaCl (Dr. Malcom
Zellars, personal communication), using a cut-off 1 ml sterile, disposable pipette tip, then
removed from the centrifuge tube and transferred to a 1.5 ml microcentrifuge tube. The starting
volume of approximately 100 ml was concentrated to a final volume of 3 ml and gently mixed by
slowly inverting the tubes 2-3 times.
DNase Treatment
One mL of the concentrated phage lysates were put into 2 mL sterile microcentrifuge
tubes (4 tubes per phage isolate). The tubes were incubated at room temperature for 15 min after
the addition of 20 µL (40 units total) of DNase to each tube. During incubation, the tubes were
carefully inverted 2-3 times every 5 min. The DNase was then heat inactivated by incubation at
75 °C for 20 min before placement on ice for 10 min.
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Protein Coat Degradation
To the DNAse treated phage preparations (now in microcentrifuge tubes) was added 20
µL of 20 mg/mL Proteinase K per 1 ml of original lysate and incubated at 55 °C for 2 hours. The
tubes were gently inverted several times every 15 min during incubation, then again after
incubation prior to starting the DNA extraction procedure.
Extraction and Purification
Each bacteriophage isolate was prepared using two DNA extraction kits. Both Qiagen
(DNeasy Blood and Tissue Kit, Cat# 69581) and Norgen (Phage DNA Isolation Kit, Cat# 46700)
spin column kits were used according to the manufacturer’s instructions. Extracted DNA was
stored at -20 °C until further use.
Phi29 Polymerase Amplification
If the concentrations of purified DNA were over 10 µg/µL, the samples were directly
sequenced by Illumina sequencing. If they were below 10 µg/µL, the samples were amplified
using a GE Healthcare illustra Ready-To-Go GenomiPhi V3 DNA Amplification Kit by
following the manufacturer’s instructions.
Illumina Sequencing
Prepared purified DNA was sent to Andrew Krohn at Northern Arizona University for
sequencing.
Data Analysis
Data obtained from Illumina sequencing is being fully analyzed by Philippos Tsourkas
using Geneious, a software program specifically for DNA and protein sequence analysis.

Acknowledgements
This research was supported by USDA Grant NEVR-2010-03755. We would like to thank the
following individuals for assistance with research: Lucy LeBlanc and Erin Davis.
84

APPENDIX B

RAPID CHARACTERIZATION OF PAENIBACILLUS SPP. BY MATRIX-ASSISTED
LASER DESORPTION/IONIZATION TIME-OF-FLIGHT
MASS SPECTROMETRY (MALDI-TOF MS)

FORWARD
This appendix is a compilation of work conducted by multiple individuals: Beau M.
Grothendick, Lin Zhang, Drs. Penny Amy and Todd Sandrin, and myself. I do not take credit for
the research presented other than my own. My contribution to the research of this manuscript
was conducted under the direction of Dr. Penny Amy and is solely the isolation and culturing of
Paenibacillus species sent to Dr. Todd Sandrin for further analysis.
This appendix is formatted for submission to Microbiological Research.
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Abstract
Characterizing Paenibacillus species using biochemical tests and molecular methods is
time-consuming and cannot effectively control the quick spread of the honey bee disease.
Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS)
has been successfully used to characterize many bacteria at the species, and in some cases, strain
levels, suggesting that MALDI-TOF MS is a promising tool to rapidly characterize Paenibacillus.
Thus, the aims of this work were to: 1) develop a method to characterize Paenibacillus using
MALDI-TOF MS and 2) identify potential biomarkers that afford resolution of Paenibacillus at
the species and strain levels. Mass spectra from 18 isolates, 12 of which were P. larvae strains,
were collected and clustered to examine the similarity between isolates. 16S rDNA sequencing
was conducted for selected isolates to compare taxonomic resolution of MALDI to PCR-based
approaches. Results show that MALDI-TOF MS can generate highly reproducible mass spectra
with an average reproducibility of 98.6%. Spectra clustered at the species and strain levels, with
the exception of three isolates. In contrast, individual strains were not discernible based on 16S
rDNA sequences. Potential biomarkers were identified in three species, including: P. larvae, P.
lentimorbus, P. polymyxa, and one previously defined subspecies, P. larvae pulvifaciens. Our
results suggest that MALDI-TOF MS based characterization is an effective tool to rapidly
characterize Paenibacillus, and affords higher taxonomic resolution than traditional PCR-based
methods.

Keywords: Bacterial characterization, strain, biomarkers, mass spectrometry, Paenibacillus,
foulbrood disease
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Introduction
Paenibacillus are found in a wide array of environments, including soil, water, vegetable
matter, and insect larvae (Antúnez et al, 2004; Genersch, 2007; McSpadden, 2004; Rieg et al,
2010), some of which are pathogens. For example, Paenibacillus larvae, a gram-positive spore
forming bacterium, is the causative agent of American Foulbrood disease (AFB) (Genersch
2008). AFB is a severe honey bee disease that often kills the hive brood (Lindstrom et al, 2008a,
2008b). The spores are the infectious agent of P. larvae, which cannot be treated with antibiotics
and are resistant to heat (Hamdi et al, 2013). Once the hive is infected, the spores are not easily
removed and thus they spread between hives quickly. Infected hives and beekeeping equipment
are usually burned to control the spread of AFB (de Graaf et al, 2006), causing massive financial
destruction to apicultural industries (Antúnez et al, 2004; Hamdi et al, 2011). Moreover,
emergent strains with varied virulence and antibiotic resistance have appeared throughout history
in different regions of the world (Genersch et al, 2005; Rieg et al, 2010; Tian et al, 2012). The
genetic diversity of P. larvae strains makes the control of AFB even more difficult.
To properly diagnose AFB, many methods have been developed to identify P. larvae and
differentiate it with respect to related Paenibacillus species. These methods include catalase test,
REP-PCR using BOX primers, and 16S rRNA gene sequencing (Alippi et al, 1998; Genersch et
al, 2006; Govan et al, 1999). These methods are effective to identify P. larvae at the species level
and, in some cases, type the diversity of intra-species. However, they are extremely timeconsuming. Honey bee larvae are fed royal jelly contaminated with P. larvae spores; the spores
germinate within 12 hours of consumption. Obviously, these traditional biochemical and
molecular methods cannot be applied in a timely manner to diagnose AFB, since none of them
can be easily completed in 12 hours.
A promising technique that can be used to rapidly identify and differentiate P. larvae is
matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) fingerprint-based
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methods. In the past decade, MALDI-TOF mass spectrometry (MS) has been incrementally and
successfully utilized to characterize many bacteria at the species, subspecies, and in some cases,
strain levels, including Bacillus which is closely related to Paenibacillus (Diekmann et al, 2010;
Mazzeo et al, 2006; Sandrin et al, 2013; Teramoto et al, 2007). Unique fingerprints in the form of
mass spectra can be obtained from intact cells or the extracted proteins of pure cultures following
previously published protocols (Friewald and Sauer, 2009). The preparation techniques are
simple and do not require large amounts of biological materials to perform. The resulting spectra
are highly reproducible and can be used to characterize, discriminate, identify, and track bacteria.
The entire procedure can acquire only a few minutes, which enables the possibility of analyzing a
great number of samples within a short time. Studies also suggest that MALDI-TOF
fingerprinting methods have better taxonomic resolution than traditional molecular methods
(Böhme et al, 2013; Fujinami et al, 2011). These advantages engendered our interest in applying
MALDI-TOF MS to characterize Paenibacillus species. Our hypothesis was that with proper
protocols, MALDI-TOF MS can rapidly and reliably characterize Paenibacillus species and
perhaps strains.
As a result, the objectives of this study were to 1) develop and evaluate a method to
characterize isolates of Paenibacillus using MALDI-TOF MS and 2) identify potential
biomarkers that afford resolution of Paenibacillus isolates at the species, subspecies, and strain
levels. In this work, MALDI-TOF MS was applied to 18 Paenibacillus isolates, including 3
species, P. lentimorbus, P. polymyxa and P. larvae, and two previously defined subspecies, P.
larvae larvae and P larvae pulvifaciens, using a protein extraction sample preparation method. A
dendrogram was built based on the resulting mass spectra to examine the relationship between
species and previously defined subspecies. The resulting spectra were further analyzed for
potential species and strain discriminating biomarkers. Results suggest that MALDI-TOF
fingerprinting can successfully characterize Paenibacillus at the species level. For the previously
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defined subspecies level, results suggest that MALDI-TOF fingerprinting is successful, with the
exception of a single misidentified isolate.

Materials and Methods
Paenibacillus isolates and culture conditions
A collection of 18 Paenibacillus isolates representing three species and two previously
defined subspecies were used in this study (Table 1). Isolates were stored at -80°C in a 20%
glycerol/ R2B medium. Isolates were cultured on R2A plates (Difco, BD Diagnostics, Sparks,
MD, USA) at 37°C for 48 h. Single colonies were selected to inoculate R2B (Difco, BD
Diagnostics, MD, USA). Inoculated broth was incubated at 37°C for 24 to 48 h (due to differing
growth rates) on an orbital shaker at 200 rpm.
Sample preparation
A protein extraction sample preparation method was used (Friewald and Sauer, 2009). Cells
from R2B cultures were pelleted by centrifugation (17,000 × g for 5 min) and washed with sterile
double-distilled water (ddH2O) (Millipore Corp.; Bedford, MA, USA) to remove pigment. Cells
were re-suspended in sterile ddH2O and the cell density of each suspension was adjusted to 1.0 ±
0.1 OD600. Each cell suspension was pelleted by centrifugation (17,000 × g for 5 min) and the
supernatant was carefully removed. Cell pellets were inactivated in 450 µL of absolute ethanol
(200 proof) and 150 µL sterile ddH2O. Each sample was centrifuged (17,000 × g for 5 min) and
the resulting supernatant was discarded. Five microliter of 70% formic acid (Sigma-Aldrich, St.
Louis, MO, USA) and 5µL of acetonitrile (Alfa Aesar, Ward Hill, MA, USA) were mixed with
the pellet by pipetting thoroughly. Each sample was centrifuged (17,000 × g for 5 min), and the
supernatant was transferred into a sterile 1.5 mL microcentrifuge tube. Protein extract (0.5 µL)
was pipetted onto a polished steel 96-well MALDI target plate (Bruker Daltonics) and allowed to
air-dry for ten minutes. Samples were spotted on predetermined, randomly distributed locations
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on the target plate and were coded numerically. After the sample had dried, it was overlaid with
0.5 µL of α-cyano-4-hydroxycinnamic acid (ACROS, Fair Lawn, NJ, USA) matrix supplemented
with 2.5% trifluoroacetic acid (ACROS, Fair Lawn, NJ, USA). Each isolate was spotted in
triplicate.
MALDI-TOF MS data acquisition
MALDI-TOF MS analyses were performed using a Bruker Microflex LRF MALDI-TOF
mass spectrometer (Bruker Daltonics; Billerica, MA) equipped with a nitrogen laser (337 nm)
under the control of FlexControl software (version 3; Bruker Daltonics). Each spectrum was
obtained in a linear positive mode and calibrated externally using Angiotensin II (1046.54 Da),
ACTH (1-17) (2094.427Da), ACTH (18-39) (2466.681 Da), Insulin oxidized B (3494.651 Da),
Insulin (5734.518 Da), Cytochrome C (1236.974 Da), and Myoglobin (16952.306 Da). Five
hundred shots were collected manually in 100 shot steps for each spot within a mass range from 2
to 20 kDa. Laser power was set to the necessary minimum for ionization of selected samples
before starting the analyses. After each round of 100 shots, the operator added the spectrum to
the sum buffer only if the base peak of the resulting spectrum had an intensity of approximately
1,000 a.u. or greater.
Spectrum cluster analysis
Mass spectra contained in .txt files were extracted from FlexAnalysis (version 3.0;
Bruker Daltonics) and then imported into Bionumerics (version 7.1; Applied Maths). Spectra
were pre-processed using the following settings: baseline subtraction (rolling disc; disc width
201 points), smoothing (Kaiser Window filter; Window size: 20, Beta: 20), peak detection (CWT
Ridges algorithm; minimum wavelet scale: 2, maximum wavelet scale: 16, minimum local ridge
length: 2 scale, minimum total ridge length: 12 scale, max number of ridge gaps: 3, edge
enhancement), and peak filtering (S:N ratio of 10). Reproducibility of triplicate spectra within a
sample was calculated as previously described (Schumaker et al, 2012). Then, the triplicate
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spectra were condensed into a single composite (summary) spectrum. For cluster analysis, the
composite spectra were further processed using 1% curve smoothing and the Pearson correlation
coefficient between composite spectra was calculated. A dendrogram was generated using an
unweighted pair group method with an arithmetic mean (UPGMA) algorithm based on the
Pearson correlation coefficients. Multidimensional scaling (MDS) analysis was performed as
previously described to visualize the similarity between composite spectra (Goldstein et al, 2013).
Jackknife analysis was performed using maximum similarities to further quantify the rates of
correct classification between species and subspecies.
16S rDNA sequencing
Genomic DNA was isolated by freezing and thawing cell cultures three consecutive times.
The cells were centrifuged (17,000 × g for 5 min) and the resulting supernatant was transferred to
a new sterile microcentrifuge tube. The primers used for 16S rDNA sequencing were 27f (5’
AGA GTT TGA TCC TGG CTC AG 3’) and 1492r (5’ TAC GGT TAC CTT GTT ACG ACT T
3’). Each 20-µl reaction contained 0.5 µM of each primer, 0.2 mM of each dNTP, 1X phusion
HF buffering consisting of 10mM Tris-HCL, 50mM KCL, 2.0 mM MgCL (PH 8.3), 3% DMS0,
0.02 U/µL of taq DNA polymerase, and 10.8 µL UV sterilized ddH2O. The amplification cycle
was 95°C for 5 min, followed by 30 cycles of 98°C for 10 sec, 55°C for 30 sec, and 72°C for 30
sec, and a final extension at 72°C for 10 min. PCR products were purified using a QIAquick
PCR Purification Kit (QIAGEN) as recommended by the manufacturer and sent to Arizona State
University DNA lab for sequencing. The sequenced products were proofread using FinchTV
(Geospiza, Seattle WA). All DNA sequences were assembled and aligned in Bionumerics
(version 7.1; Applied Maths). Similarity searches for sequences were performed using BLAST
analysis. A pairwise alignment of about 700 base pairs of each isolate was performed (Open gap
penalty: 100%, Unit gap penalty: 0%) and a tree was constructed based on alignment scores using
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single linkage network creation algorithm with Jukes and Cantor correction (Gap Penalty: 2%).
The root was determined using the maximum branch length.
Identification of potential biomarkers
Raw mass spectra were imported into FlexAnalysis software (version 3.0; Bruker Daltonics),
and baseline subtraction was applied using the TOPHAT algorithms. Peaks were picked using
the following parameters: masses from 2 to 20 kDa, minimum peak resolution at 400 Da,
minimum signal to noise at 2, minimum intensity threshold at 100. The picked peaks were
manually organized in a list of highest to lowest intensity. Replicate peaks (i.e., potential
biomarkers) found unique and exclusively reoccurring in one species, subspecies, or strain were
identified and their collective m/z was averaged. The average peak m/z was compared against the
individual minimum and maximum m/z values within the exclusive species, subspecies, or strain.
If the difference of values was less than or equal to ±2.0 m/z, the potential biomarker was
recorded. If the difference was greater than ±2.0 m/z, or a similar peak was found outside of the
specific species, subspecies, or strain, the potential biomarker was not recorded.

Results and Discussion
Paenibacillus species, for example, P. larvae, are pathogens that cause severe disease (AFB)
of honey bees, which results in a huge economic loss in agricultural industries. MALDI-TOF MS
is rapid and easy to perform, offering an alternative method to traditional PCR-based methods,
which may contribute to rapidly identifying P. larvae and limiting the spread of AFB. As a
result, the purpose of this study was to evaluate the possibility of MALDI-TOF MS rapidly
characterizing the Paenibacillus species using a model of eighteen Paenibacillus isolates. These
isolates were either isolated from larvae scales or purchased from culture collection centers
(Table 1). The wild type isolates were identified using specific Paenibacillus primers (Piccini et
al, 2002) (Table 1).
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Method development
MALDI-TOF MS spectra were generated from protein extracts of Paenibacillus isolates
with three technical replicates for each isolate. While intact cell methods are more favorable than
protein extraction for rapid characterization, preliminary experiments using ethanol to inactivate
bacterial whole cells failed. Significant colony growth was observed from treated cells streaked
onto R2A plates within a period of five days (data not shown). This may be due to that
Paenibacillus species are spore-forming bacteria and ethanol was not able to kill all the spores.
Other inactivation methods, such as increasing inactivation time, using acetonitrile instead of
ethanol, and using low pressure plasma, may be used in the future to facilitate the use of more
rapid intact cell methods to further increase the efficiency of MALDI-TOF-based characterization
of Paenibacillus.
Cultivation times for each environmental isolate were not uniform. Visible growth was
not apparent in New Mexico strains, NW1 and NW2 (Table 1), for up to five days. P. larvae
pulvifaciens and P. polymxa cultures consistently showed visible growth after a 24 h period,
while P. larvae larvae and P. lentimorbus cultures varied dramatically in time required for visible
growth (24h – 72h). Some studies suggest that cultivation time affects the resulting mass
fingerprints and this may affect reproducibility of replicates (Šedo et al, 2013). However,
environmental isolates often have heterogeneous growth rate. To minimize the effect of
cultivation time on spectrum reproducibility, the average rate of each isolate’s growth, which
ranged from 24 h to 120 h, was charted to sync cultivation of cells for MALDI-TOF MS.
Specifically, each isolate had visible turbidity after the following estimated times: NM1, NM2,
WA (120 h); 16425 (96 h); P. lentimorbus 1, P. lentimborbus 2, 2605 (72 h); 3554 (48 h); P.
polymyxa, 232, 367, 368, 747, 748, 843, 2231, 2188, 3688 (24 h).
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Representative mass spectra
Previous studies indicate that manual data acquisition can generate more reproducible
mass spectra than automated data acquisition (Schumaker et al, 2012). Reproducibility of mass
spectra is a very important factor to evaluate the performance of MALDI-TOF MS in bacterial
characterization, and high reproducibility is critically important, especially at the strain level
(Sandrin et al, 2013). Thus, in this study, manual data acquisition was used to maximize the
reproducibility of Paenibacillus mass spectra to better evaluate the ability of MALDI-TOF MS to
differentiate P. larvae strains. The minimum reproducibility of each triplicate across all isolates
was 96.4% and the maximum reproducibility was 99.9%. The averaged reproducibility of all
technical replicates was 98.6% (± 0.98). The resulting reproducibility was comparable to or
better than those reported in other MALDI-TOF fingerprint studies (Schumaker et al, 2012;
Goldstein et al, 2013; Wunschel et al, 2005), suggesting that MALDI-TOF MS can generate
highly reproducible mass spectra of Paenibacillus by using a protein extraction method with
manual data acquisition. Our model system contained only 18 isolates. In case of large number
of samples, the automated data acquisition is more favorable and applicable with automated
parameter optimization.
Representative mass spectra of P. polymyxa, P. lentimorbus, and two previously defined
subspecies, P. larvae larvae and P. larvae pulvifaciens, are displayed in Figure 1. Spectra
produced by different Paenibacillus species were readily distinguished from one another based on
their mass ranges and base peaks. Specifically, P. polymyxa yielded spectra with most peaks in
the range of 2,000 – 11,200 Da (Fig. 1A); P. lentimorbus yielded spectra with most peaks below
9,800 Da (Fig. 1B); P. larvae yielded peaks in a similar mass range, 2000 – 10,300 Da, to that of
P. polymyxa, but less peaks were shown above 10,000 Da than that of P. polymyxa (Fig. 1C and
D). With regards to strain level characterization, P. larvae larvae and P. larvae pulvifaciens
showed similar mass profiles at first glance, but P. larvae pulvifaciens has a high intensity peak
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(8517.1 Da) in the mass range of 8,000 to 9,000 Da, while no peaks or very low intensity peaks
were observed in this range in the mass profiles of P larvae larvae (Fig. 1C and D). This
suggests that MALDI-TOF MS can support the strain level differentiation of P. larvae based on
specific peaks or the potential biomarkers. With regards to the base peak, each examined was
found to be unique to its taxon. At the species level, the base peaks of P. polymyxa, and P. larvae
were 4298.8 Da and 4285.3 Da, respectively (Fig. 1). Interestingly, the base peak of P.
lentimorbus shifted depending on the spectrum analyzed. Its base peak can either be 4289.7 Da
or 5106.4 Da (Fig. 1B). This may be due to the protein expression variability during cultivation.
At the strain level, the same base peak was observed for P larvae larvae and P. larvae
pulvifaciens (Fig. 1 C and D). These data indicate that, in our model system, MALDI-TOF MS
can rapidly distinguish Paenibacillus at the species and the strain levels based on the whole mass
profiles and/or potential biomarker peaks.
Mass spectra cluster analysis
A dendrogram of mass spectra of Paenibacillus was constructed to examine the similarity
between isolates. Isolates with similar spectra were grouped together as one cluster (Fig. 2).
Each mass spectrum is also represented in a gel-view format (Fig. 2). As shown in Figure 2, most
of the species are clearly differentiated by MALDI. Specifically, P. larvae, P. lentimorbus and
the New Mexico isolates (identified as P. lautus) formed distinct clusters in the dendrogram (Fig.
2). The P. polymyxa isolate was not clustered with any of these groups, suggesting that this
species can be distinguished from other Paenibacillus species (Fig. 2). Closely related strains, P.
larvae larvae and P. larvae pulvifaciens are also separated as two clusters, suggesting that
MALDI-TOF MS is potentially able to characterize P. larvae at the strain level (Fig. 2).
However, outliers were also observed in the MS data. P. larvae larvae isolates 2231, 3554, 2188,
748, and 747 grouped together consistently, while P. larvae larvae 2605 and the Washington
isolate grouped together as outliers (Fig. 2). The gel views of these two isolates show different
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profiles compared with gel representations of other P. larvae isolates (Fig. 2). To eliminate the
possibility that these two isolates were not P. larvae species, 16S rDNA sequencing was
conducted and BLAST analysis confirmed that these two isolates belonged to P .larvae (Table 2).
Similarly, P. larvae pulvifaciens isolates 367, 368, and 843 grouped together consistently, while
P. larvae pulvifaciens 3688 grouped together with P. larvae larvae isolates (Fig. 2). The
appearance of outlier isolates indicates that other parameters may affect the correct identification
and classification of P. larvae. It is important to note that the clustering analysis of mass spectra
does not establish phylogenetic relationships. The appearance of outliers may be due to the mass
shifts of group-specific peaks resulting from amino acid exchanges in the respective proteins
(Dieckmann et al, 2005). Another possible explanation is that these two isolates required longer
cultivation time than other P. larvae isolates and lengthy cultivation times may affect strain
classification (Šedo et al, 2013). In addition, studies indicate that processing criteria of mass
spectra may affect bacterial identification (Ford and Burnham, 2013). Our preliminary
experiments also showed that raw mass spectra processing parameters affected the clustering
pattern (data not shown). Future experiments to optimize cultivation conditions and processing
parameters are of great interest in our lab to further improve the taxonomic resolving power of
MALDI-TOF MS for P. larvae.
The Jackknife method was performed to more rigorously evaluate the ability of MALDITOF MS to distinguish P. larvae larvae and P. larvae pulvifaciens. The principle of the
Jackknife analysis is to take out one “isolate” and develop a classification function using the
remaining isolates. The omitted isolate is then “classified” into one group (in our case, defined as
P. larvae larvae or P. larvae pulvifaciens) using the classification function constructed. This
procedure was repeated for all P. larvae strains, and a 100% identification score means no
mismatch. The jackknife maximum similarity analysis between previously defined subspecies
larvae and pulvifaciens resulted in a 100% match between P. larvae larvae isolates and a 75%
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match between P. larvae pulvifaciens (Fig.2), indicating that P. larvae pulvifaciens 3688
consistently clustered with P. larvae larvae under our experimental condition.
A multi-dimensional scaled model (MDS) was used to further examine the similarity of
each isolate resulting in a visual cue of differences between outliers and grouped isolates (Fig. 3).
Similar to the results of cluster analysis, P. larvae pulvifaciens 3688 (A) can be seen clustering
closer to P. larvae larvae isolates and farther away from other P. larvae pulvifaciens isolates (Fig.
3). P. larvae 2605 (B) and WA (C) have a large difference in space compared to both P. larvae
subspecies, suggesting these two isolates are outliers (Fig. 3). Both New Mexico isolates have a
considerable difference of space between their optimized positions, suggesting that though these
two isolates clustered as one group, they show a relatively high variability in their mass profiles.
In contrast, both P. lentimorbus isolates overlap each other’s optimized positions, suggesting a
high degree of similarity between the two strains (Fig. 3).
Phylogenetic analysis of 16S rDNA sequences
To compare the taxonomic resolution of MALDI-based and PCR-based approaches for
Paenibacillus species and strains, the 16S rRNA genes of selected isolates were partially
sequenced. BLAST analysis shows that all selected P. larvae isolates could be correctly
identified at the species level (Table 2). P. lentimorbus was only correctly identified at the genus
level (Table 2). P. polymyxa was identified as Bacillus genus (Table 2). This may be due to that
Paenibacillus was originally included within the genus Bacillus. The representative (NM2) of
New Mexico isolates was identified as P. lautus (100%), which explained the mass spectra
clustering result that these two isolates clustered together but separately from other groups (Table
2, Figure 2). With regard to the strain level identification, P. larvae larvae and P. larvae
pulvifaciens were indistinguishable from each other based on BLAST analysis (Table 2).
Thirteen representative isolates were chosen for pairwise alignment cluster analysis, and
constructed into a tree using 16S rDNA sequences (628–897 bp). As shown in Figure 4, there is
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no differentiation between P. larvae larvae and P. larvae pulvifaciens (Fig. 4). All P. larvae
strains were grouped together with no marginal differences in species identity. P. polymyxa, P.
lentimorbus, and NM2 have a greater distance from P. larvae. The taxonomic resolution was
lower than that of MALDI-TOF mass spectrometry in all regards.
Potential Biomarkers
Since outliers were observed in the case of some P. larvae larvae and P. larvae
pulvifaciens strains, we further screened entire spectra for species/strain-identifying biomarkers.
Species-specific potential biomarkers were recorded for P. polymyxa, P. lentimorbus, and P.
larvae, which are shown in Figure 5 and tabulated in Table 3. Specifically, P. polymyxa has five
distinguishing potential biomarkers at 3686.0, 4298.5, 4344.7, 6607.7, and 9809.0 Da (Fig. 5A,
Table 3). P. lentimorbus has five distinguishing potential biomarkers at 3313.3, 4290.0, 5130.7,
5963.4, and 6444.5 Da, three at relative low intensity (<1,000 a.u.) (Fig. 5B, Table 3). P. larvae
has five distinguishing potential biomarkers at 3018.6, 4286.0, 5172.2, 7519.3, and 9614.6 Da,
one at relative low intensity (<1,000 a.u.) (Fig. 5C, Table 3). The subspecies P. larvae larvae
exhibited no distinguishing potential biomarkers (Table 3). P. larvae larvae has previously been
reported to show a range of virulence dependent on the genotype (Genersch E, 2005), which
suggests different protein profiles. This may account for the lack of subspecies specific potential
biomarkers. The lack of more strain specific potential biomarkers may also be attributed to
gradual shifts in mass, affected by distances in preparation time (Keys CJ et al, 2004) over several
runs. The subspecies P. larvae pulvifaciens has five more distinguishing potential biomarkers
beside the potential biomarkers of P. larvae at 2675.17, 6134.0, 6347.4, 7311.2, and 7398.5 Da
(Figure 5D, Table 3). Four of the potential biomarkers are of relatively low intensity (<1,000
a.u.).
P. larvae pulvifaciens 3688 was an outlier. Its mass spectrum was clustered with the
mass spectra of P. larvae larvae isolates (Fig. 2). Examination of potential biomarkers showed
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that this isolate only had one distinguishing potential biomarker, 6347.4 Da, for identifying it as
P. larvae pulvifaciens. It lacked the other potential biomarkers that have denoted 75% of all other
P. larvae pulvifaciens isolates. The lack of potential biomarkers similar to those of P. larvae
pulvifaciens may explain the misclassification of strain 3688 with P. l. larvae. With regard to the
two other outliers, P. larvae larvae 2605 and WA, each was identified as P. larvae larvae using
potential biomarkers.

Conclusion
The main objective of this study was to evaluate the ability of MALDI-TOF MS to
characterize Paenibacillus at the species and strain levels. Results showed that each
Paenibacillus species yielded highly reproducible spectra and individual characteristic traits using
the protein extraction sample preparation method. Based on the spectra, isolates were clustered
and differentiated according to their species and subspecies, though outliers were also observed.
In contrast, 16S rDNA sequencing only identified the isolates at the genus and species level.
Potential biomarkers have been examined for individual species and subspecies to further
facilitate the characterization. Our results suggest that MALDI-TOF MS is much more rapid and
affords a higher resolution characterization of Paenibacillus than PCR-based methods. To our
knowledge, this is the first study to use MALDI-TOF MS to characterize Paenibacillus at the
species, subspecies, and strain levels. Future studies to construct and optimize a more diverse
Paenibacillus database for discriminating and identifying unknown Paenibacillus isolates, as well
as typing and tracking P. larvae outbreaks are of great interest.
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Table 1 Paenibacillus isolates used in this study
Previous
subspecies
classification

Designated
ID

Isolationb

Pigmentation

P. larvae

larvae

747

ATCC 25747, isolated from insect, OH, USA

-

P. larvae

larvae

748

ATCC 25748, isolated from insect, VA, USA

-

P. larvae

larvae

2188a

Isolated from larvae scales, courtesy of Jay D
Evans (USDA)

-

P. larvae

larvae

2231a

Isolated from larvae scales, courtesy of Jay D
Evans (USDA)

-

P. larvae

larvae

2605

ATCC 9545, isolated from insect

-

P. larvae

larvae

3554

NRRL B-3554, isolated from diseased
honeybee larvae

-

P. larvae

larvae

16425

Isolated from larvae scales, Belgium

-

P. larvae

larvae

WAa

Isolated from larvae scales, Washington State

-

P. larvae

pulvifaciens

367

ATCC 25367

+

P. larvae

pulvifaciens

368

ATCC 25368

+

P. larvae

pulvifaciens

843

ATCC 49843, isolated from honeybee larvae

+

P. larvae

pulvifaciens

3688

ATCC 13537, isolated from diseased
honeybee

+

P. sp.

N/A

NM1

Isolated from larvae scales, New Mexico

-

P. sp.

N/A

NM2

Isolated from larvae scales, New Mexico

-

P. sp.

N/A

232

Wild strain

-

P. lentimorbus

N/A

P.
lentimorbus1

ATCC strain

P. lentimorbus

N/A

P.
lentimorbus2

ATCC strain

P. polymxya

N/A

P. polymxya

ATCC strain

Species

a

-

-

-

Positive with P. larvae specific primers
obtained from ATCC website, ARS Culture Collection (NRRL) Database Server, and straininfo.net
N/A: not applicable/available
b Information
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Table 2 Nearest relatives of selected Paenibacillus isolates by 16S rDNA sequencing
Designated ID
747
748
2188
2231
3554
16425
WA
367
843
3688
NM2b
P. polymyxa
P. lentimorbus1

Nearest relative (Accession
#) a
AB073205.1
DQ07623.1
AB073205.1
AY530294.1
AB073205.1
DQ07623.1
AY530294.1
AY030080.1
AY530294.1
AB680856.1
FR775438.1
KF512664.1
AB073200.1

% Similarity

Representative of group

99
99
99
99
99
99
99
100
99
99
99
100
99

P. larvae larvae
P. larvae larvae
P. larvae larvae
P. larvae larvae
P. larvae larvae
P. larvae larvae
P. larvae larvae
P. larvae pulvifaciens
P. larvae pulvifaciens
P. larvae pulvifaciens
P. lautus
P. polymyxa
P. lentimorbus

a Based
b

on a BLAST search of the NCBI database
Forward and reverse sequences only available for identification; no assembled sequence available

Table 3 Potential biomarker peaks of Paenibacillus
Paenibacillus species/subspecies Mass of potential biomarker (Da)
P. polymyxa
3686.0, 4298.5a, 4344.7, 6607.7, 9809.0
P. lentimorbus
3313.3b, 4290.0a, 5130.7, 5963.4b, 6444.5b
P. larvae
3018.6b, 4286.0a, 5172.2, 7519.3, 9614.6
P. larvae larvae
N/A
P. larvae pulvifaciens
2675.2, 6134.0, 6347.4b, 7311.2, 7398.5
a Base peak in the mass spectra of the corresponding Paenibacillus species and subspecies
b Peak intensity lower than 1,000 a. u.
N/A: not available
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Figure 1. Representative MALDI-TOF mass spectra of A) Paenibacillus polymyxa, B) Paenibacillus lentimorbus, C)
Paenibacilllus larvae larvae and D) Paenibacillus larvae pulvifaciens
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Figure 2. Dendrogram of Paenibacillus isolates. Each mass spectrum is represented in a gel-view format. The
dendrogram was constructed using the UPGMA method from calculated distances using Pearson correlation similarity
matrix in BioNumerics software. The coding colors are P. polymyxa (yellow), P. lentimorbus (light blue), P. larvae
larvae (green), P. larvae pulvifaciens (red), New Mexico isolates (P. lautus) (purple), and P. sp. 232 (dark blue).
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Figure 3. Multi-dimensional scaling (MDS) representation of composite-spectra. The coding colors are P. polymyxa
(yellow), P. lentimorbus (light blue), P. larvae larvae (green), P. larvae pulvifaciens (red), New Mexico isolates (P.
lautus) (purple), and P. sp. 232 (dark blue).
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Figure 4. Phylogenetic tree of Paenibacillus isolates based on partial 16S rRNA gene sequences. The tree was
generated using the single linkage method from calculated distances using Pairwise alignment similarity matrix in
BioNumerics software. The coding colors are P. polymyxa (yellow), P. lentimorbus (light blue), P. larvae larvae
(green), P. larvae pulvifaciens (red), New Mexico isolates (P. lautus) (purple), and P. sp. 232 (dark blue).
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Figure 5. Species/subspecies-specific potential biomarkers (depicted with asterisks) of A) Paenibacillus polymyxa, B)
Paenibacillus lentimorbus, C) Paenibacillus larvae larvae and D) Paenibacillus larvae pulvifaciens
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